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CHAPTER I 
 
Introduction 
 
The catecholamines, dopamine and norepinephrine, are modulatory 
neurotransmitters that influence synaptic transmission widely in the brain. 
Norepinephrine (NE) is involved in stress, arousal, cognitive performance, and the 
maintenance of homeostasis (Abercrombie et al., 1988; Aston-Jones and Cohen, 2005; 
Blessing and Willoughby, 1985; Clayton et al., 2004; Hilaire et al., 2004; Korf et al., 
1973; Rinaman, 2003). The dopamine (DA) system plays a role in a variety of functions 
including controlling motor functions, motivated behavior, natural or drug related reward, 
associative learning, and mood (Bromberg-Martin et al., 2010; Fields et al., 2007; Grace 
et al., 2007; Ikemoto and Bonci, 2014; Meye and Adan, 2014; Nestler and Carlezon, 
2006; Nikulina et al., 2014; Walsh and Han, 2014). The catecholamines exert a 
modulatory role on neurotransmission and signal through G protein-coupled receptors 
(GPCRs). They can act either pre-synaptically to influence synthesis and release of 
neurotransmitter at the terminal and firing of the neuron at the somatodendritic level or 
post-synaptically to influence the action of the neurotransmitter. NE is known to 
innervate DA neurons and may work to fine tune the actions of DA, a process termed 
metamodulation (Katz and Edwards, 1999). The dysfunction of the midbrain DA system 
can contribute to many diseases such as Parkinson’s disease, schizophrenia, attention 
deficit hyperactivity disorder (ADHD), mood disorders, and drug abuse (Barrot, 2014). 
Understanding the complicated midbrain DA system, and its interactions with NE, is 
2	  
	  
critical to understanding the development of these disorders and gain insights into novel 
therapeutics for the treatment of these diseases. The mesotelencephalic DA system 
arises from neurons located in midbrain areas that have a wide range of projection 
targets. Dopamine acts through five distinct GPCR subtypes. The five subtypes are 
divided into two classes. The D1 receptor family contains subtypes D1 and D5 that are 
coupled to Gs and the D2 receptor family contains subtypes D2, D3, and D4 which are 
coupled to Gi/o (Missale et al., 1998). The D2 receptors often act as autoreceptors to 
inhibit synthesis and release of DA and regulate the firing of the neuron (Deutch and 
Roth, 1990). The dynamics of dopamine release are critically tied to the behavioral 
actions of DA. In order to understand how DA is released we must first examine the DA 
neurons controlling the release. This introduction will discuss the heterogeneity and 
function of DA neurons, the role of DA in stress, and NE modulation of DA neurons. 
 
History and organization of the catecholamine systems 
The catecholamine neurons were first visualized in the early 1960s. Prior to the 
widespread use of selective antibody immunohistochemistry techniques, Bengt Falck 
and Nils-Åke Hillarp developed a novel histofluorescence method that allowed 
visualization of the monoamines, which include serotonin, dopamine, norepinephrine, 
and epinephrine, within the central and peripheral nervous system (Falck et al., 1962). 
The Falck-Hillarp fluorescence method is based on the exposure of freeze dried tissue 
to formaldehyde vapor which converts dopamine and norepinephrine to iso-quinoline 
molecules that emit a yellow-green fluorescence under the microscope. This is the first 
3	  
	  
method that allowed visualization of monoamines within neurons and gave the first 
conclusive evidence of monoamines as neurotransmitters.  
Following the development of the Falck-Hillarp fluorescence method, 
investigations of the catecholamine systems flourished. The catecholamine cell groups 
were first mapped by Annica Dahlström and Kjell Fuxe in 1964. Dahlström and Fuxe 
assigned the groups labels starting with the letter A for “aminergic.” A1-A7 are groups of 
noradrenergic neurons while groups A8-A12 contain dopamine (Dahlström and Fuxe, 
1964). The basic organization of the catecholamine cell groups by Dahlstöm and Fuxe 
stands up today, however, later modifications on the Falck-Hillarp method and the use 
of immunohistochemical methods have allowed for greater sensitivity and precision in 
the identification of catecholamine cell groups. Five additional DA cell groups, A13-A17 
and three epinephrine cell groups C1-C3 were added (Hokfelt et al., 1984). A summary 
of the anatomical location of the NE and DA cell groups are in Table 1. Norepinephrine 
arises from the locus coeruleus (A4 and A6 areas) and ventral medulla (A1, A5 and A7 
areas) or dorsomedial medulla (A2 area). The majority of DA neurons arise from 
midbrain (A8-A10) and hypothalamic groups (A11-A15). The A9 group contains the DA 
neurons of the substantia nigra (SN) which heavily project to the striatum and play a 
large role in motor control.  
The A10 group consists of the DA neurons of the ventral tegmental area (VTA) 
which heavily project to the nucleus accumbens (NAc) and prefrontal cortex (PFC) and 
are involved in motivated behavior and reward. The original “A” nomenclature has 
retained well because many of the catecholamine cell groups are not defined to one 
anatomical region, and there are species variations among the distributions of the cell 
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groups (Bjorklund and Dunnett, 2007; Hokfelt et al., 1984). As well as the discovery of 
additional groups, further refinements in nomenclature have occurred. In 1979, the A10 
group (VTA) was subdivided into four distinct nuclei based on cytoarchitecture 
(Phillipson, 1979a). The four nuclei of the A10 group are the parabrachial pigmented 
(PBP), paranigral, interfascicular, and caudal linear nuclei. The rostral linear nucleus 
(RLi) is composed of small and round neurons, and Phillipson suggested the RLi was 
likely a caudal extension of the A11 cell group and considered it independent to the VTA 
(Phillipson, 1979a). In contrast to the A11 cell group, few RLi fibers enter the 
periventricular path to innervate diencephalic areas and none innervate the spinal cord 
(Del-Fava et al., 2007). In 1987, it was suggested by Oades and Halliday that the rostral 
linear nucleus (RLi) be incorporated into the A10 group based on anatomical 
connections and more recent anatomical data support this idea (Del-Fava et al., 2007; 
Oades and Halliday, 1987). The VTA is usually thought of as an anatomical entity 
because its outputs do not reflect VTA cytoarchitectural nuclear divisions (Oades and 
Halliday, 1987; Phillipson, 1979a), but are instead organized topographically (Beckstead 
et al., 1979; Fallon and Moore, 1978). For this reason, it is useful in this dissertation to 
refer to lateral and medial VTA areas, with “lateral” generally referring to lateral areas of 
the PBP and paranigral nuclei and “medial” referring to medial areas of the PBP and 
paranigral nuclei, as well as the RLi and CLi. A caveat to the distinction between medial 
and lateral VTA areas is that although this terminology is a useful means of discussing a 
broad trend, these separations are not absolute. 
In 1984, Hökfelt et al. proposed that the tyrosine hydroxylase (TH) positive 
neurons of the dorsal raphe (DR) and periaqueductal gray (PAG) should be considered 
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a dorso-caudal extent of the A10 group and termed them the A10dc group (Hokfelt et 
al., 1984). The dopaminergic network of the PAG is composed of small and large 
neurons, and there are no clear borders separating the small DA neurons of the PAG 
and RLi (Flores et al., 2006; Hasue and Shammah-Lagnado, 2002). In addition, the TH 
positive cells anterior to the VTA in the supramammillary nucleus were termed the A10 
ventrorostral (A10vr) group (Hokfelt et al., 1984). See Figure 1 for a schematic of the 
midbrain DA neuron groups. 
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Table 1: Description of the catecholamine cell groups 
Sources: (Bjorklund and Dunnett, 2007; Hokfelt et al., 1984; Kandel, 2013; Li et al., 2014) 
7	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic of the organization of the midbrain dopamine cell 
groups in the rat brain. 
(Left) Coronal sections from the Paxinos and Watson atlas showing midbrain 
nuclei containing dopaminergic neurons. The distance from Bregma is indicated 
below each plate. (Right) The subdivisions of the VTA, as described 
by Phillipson, are shown on coronal plates of the rat modified from rat brain 
atlases. The distance from Bregma is indicated above each plate.  
Abbreviations: aopt, accessory optic tract; CLi, caudal linear nucleus; cp: 
cerebral peduncle; fr, fasciculus retroflexus; IF, interfascicular nucleus; IP, 
interpeduncular nucleus; ml, medial lemniscus; MM, medial mammillary nucleus; 
mp, mammillary peduncle; PAG, periaqueductal gray; PBP, parabrachial 
pigmented nucleus; pn, pontine nuclei; PN, paranigral nucleus; R, red nucleus; 
RLi, rostral linear nucleus; RRF, retrorubral field; scp, superior cerebellar 
peduncle; SNC, substantia nigra pars compacta; SNL, substantia nigra, lateral 
part; SNR, substantia nigra, reticular part; SuMM, supramammillary nucleus, 
medial part; tVTA, tail of the VTA; VTA, ventral tegmental area. 
*Adapted from Flores et al 2006 and Sanchez-Catalan et al 2014.	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Heterogeneity amongst ventral tegmental area (A10) dopamine neurons 
 
Electrophysiological properties 
 Original electrophysiology studies of midbrain DA neurons focused on in vivo 
recordings in the rat SN. It was determined that long duration action potentials, D2 
autoreceptor mediated inhibition of firing, and the presence of Ih, a hyperpolarization 
activated inward cation current, were properties that could be used to accurately identify 
SN DA neurons in vivo (Grace and Bunney, 1980; Grace and Bunney, 1983; Grace and 
Onn, 1989). These properties were then used to identify VTA DA neurons for in vitro 
electrophysiology studies in brain slices. However, the validity of this identification 
method has come into question (Margolis et al., 2006). In the SN approximately 85-95% 
of neurons are thought to be dopaminergic while in the VTA, only 55-60% of the 
neurons are dopaminergic (Lacey et al., 1989; Margolis et al., 2006; Swanson, 1982). 
Therefore, it is particularly important to establish accurate criteria to identify VTA DA 
neurons. Margolis et al. tried to find an accurate electrophysiological marker for VTA DA 
neurons in vitro and found that DA neurons cannot be distinguished from other VTA 
neurons by size, shape, input resistance, Ih size, or spontaneous firing rate (Margolis et 
al., 2006). In addition, some non-dopaminergic neurons of the VTA have Ih, while some 
TH positive neurons in the VTA lack Ih, and some VTA DA neurons are insensitive to D2 
agonists, while some non-DA neurons do show inhibition due to D2 receptor (D2R) 
activation (Margolis et al., 2006). 
It has been shown that the DA neurons of the A10 group are not a homogenous 
group, but have distinct molecular and physiological properties based on their projection 
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targets and anatomical location. Recent studies have shown that some TH positive 
neurons located in the medial aspects of the VTA, specifically the medial PBP and 
medial paranigral VTA nuclei, and A10dc areas lack Ih (Hnasko et al., 2012; Lammel et 
al., 2011; Li et al., 2013a).  The DA neurons of the A10 group that lack Ih primarily 
project to the medial prefrontal cortex (mPFC) and the nucleus accumbens medial shell, 
while those with Ih primarily project to the nucleus accumbens lateral shell or belong to 
the nigrostriatal pathway (Lammel et al., 2011).  Action potential width and D2R 
mediated inhibition of VTA DA neurons differ based on projection target.  NAc projecting 
DA neurons have both of these characteristics, amygdala projecting VTA DA neurons 
show neither, and PFC projecting DA neurons do show D2R autoinhibition, but have 
short duration action potentials (Margolis et al., 2008). In contrast, Lammel et al found 
that PFC projecting DA neurons lack D2R autoinhibition, while amygdala, NAc, and 
striatal projecting DA neurons are sensitive to D2R autoinhibition (Lammel et al., 2008). 
There are some methodological differences between these two studies that might 
underlie this discrepancy. The Margolis study was in young (20-36 days) rats and the 
electrophysiology recordings were done in horizontal brain slices, while Lammel and 
colleagues used slightly older mice (12 weeks) and coronal brain slices. Taken together, 
these data suggest that the classical method of identifying VTA DA neurons by long 
duration action potentials, D2R autoinhibition, and the presence of Ih leads to an 
overrepresentation of NAc projecting DA neurons and an exclusion of amygdala and 
PFC projecting DA neurons. 
 
Genetic reporter lines for identification of dopamine neurons 
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 Due to the concerns discussed above, the use of genetic reporter animal lines 
has arisen as a popular way to identify DA neurons for electrophysiology studies. 
Reporter mouse lines allow for selection of DA neurons based on expression of a 
fluorescent reporter. This is a useful strategy for the selection of VTA DA neurons and is 
necessary in regions where the distribution of DA neurons is sparse, such as regions of 
the A10dc. For example, Li et al. used a TH-eGFP BAC transgenic mouse line to 
identify DA neurons of the vPAG for electrophysiological studies (Li et al., 2013a). In 
addition to direct reporter lines, there are Cre-driver mouse lines that can be crossed to 
reporter lines such as a ROSA-tomato line or combined with Cre-dependent optogenetic 
tools. For the specific selection of midbrain DA neurons, TH-cre and DAT-cre 
(dopamine transporter) lines are commonly used. However, one large caveat to the use 
of reporter mouse lines is the fidelity of the reporter. For example, Li et al. found that the 
proportion of eGFP positive neurons in the vPAG that colocalize with TH is 
approximately 70% (Li et al., 2013a). In addition, the TH-cre lines have been found to 
exhibit non-DA cell expression patterns around VTA nuclei, particularly in midline areas 
(Lammel et al., 2015). DAT-cre driver lines seem to exhibit less ectopic expression, but 
these lines may lead to exclusion of some midline DA neurons that lack or have low 
levels of DAT expression (Lammel et al., 2015; Stuber et al., 2015). In summary, 
reporter and cre-driver mouse lines are valuable tools for the identification of midbrain 
DA neurons, but must be used with caution and the fidelity of the reporter line must be 
confirmed in the specific brain region studied.  
 
Molecular expression profiles 
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 In addition to differences in electrophysiological properties, there are differences 
in molecular expression profiles among the A10 group. Levels of dopamine transporter 
(DAT) and vesicular monoamine transporter 2 (VMAT2), which are responsible for 
reuptake of DA and packaging of DA into vesicles, respectively, are lower in some DA 
neurons of the medial VTA than those in the lateral VTA and SN (Lammel et al., 2008; 
Lammel et al., 2015; Li et al., 2013b). Levels of D2 autoreceptors are also low or lacking 
in some medial VTA DA neurons (Hnasko et al., 2012; Lammel et al., 2008; Li et al., 
2013b). Some of these medial VTA DA neurons with low DAT or D2 autoreceptor 
expression have been shown to project to the PFC (Hnasko et al., 2012; Lammel et al., 
2008; Li et al., 2013b; Sesack et al., 1998). Specifically, PFC projecting DA neurons 
lack synthesis- and impulse-modulating D2 autoreceptors, but have release-modulating 
D2 autoreceptors (Bannon et al., 1981; Chiodo et al., 1984; Deutch and Roth, 1990; 
Galloway et al., 1986). The absence or low levels of D2R mRNA in PFC projecting DA 
neurons contrasts with data from Margolis et al. discussed above that indicates PFC 
projecting DA neurons are sensitive to D2R mediated autoinhibition. These 
electrophysiology studies were performed in rats, while the mRNA expression data is in 
both rats and mice. Therefore, species differences may account for the discrepancy. An 
alternative explanation is that the two studies represent different populations of PFC 
projecting DA neurons, with one population sensitive to D2R mediated autoinhibition 
while another population lacks this property. In addition, these expression levels are all 
studies of mRNA expression which does not necessarily correlate to differences in 
expression or function of proteins. An area of interest in recent years is that a subset of 
DA neurons, which are primarily located in medial VTA areas, express the vesicular 
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glutamate transporter 2 (VGLUT2) and have the ability to corelease glutamate (Hnasko 
et al., 2010; Li et al., 2013b; Stuber et al., 2010; Yamaguchi et al., 2011). Taken 
together, these differences in molecular expression profiles and electrophysiology 
properties indicate a potential functional heterogeneity among the subsets of VTA DA 
neurons. 
 
Firing patterns of dopamine neurons 
The firing of DA neurons is characterized by a low frequency (1-8 Hz) tonic or 
pacemaker activity that is interspersed with either transient (<500 ms) phasic 
sequences of high-frequency firing (>15 Hz), called “bursts”, or transient pauses of 
activity, where DA neurons fire no action potentials (Paladini and Roeper, 2014). 
Spontaneous pacemaker firing is independent of afferent input, while bursting activity is 
activated by glutamatergic afferents, specifically stimulation of the NMDA receptor 
(Cooper, 2002; Deister et al., 2009; Grace, 1991; Overton and Clark, 1992; Seutin et al., 
1993). Increases in GABAergic inhibition are thought to underlie the pauses in DA 
neuron activity (Matsui and Williams, 2011; Paladini et al., 1999). Bursting activity leads 
to a larger increase in synaptic DA than regular firing at the same rate (Gonon, 1988) 
and is classically thought to primarily occur during presentation of reward or salient cues 
(Cooper, 2002; Schultz et al., 1993). The majority of DA neurons are strongly activated 
by reward and reward-predicting stimuli (75-90%), while a subset of DA neurons (10-
20%) are activated by punishers and conditioned aversive stimuli such as air puffs, 
hypertonic saline or electric shock (Schultz, 2010). The DA neurons that respond to 
aversive stimuli may be more frequently encountered in more medial regions of the 
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VTA, where a high concentration of DA neurons project to the PFC (Brischoux et al., 
2009; Lammel et al., 2011). In the PFC and amydgala there is a more sustained DA 
release pattern than in the striatum (Garris and Wightman, 1994). Lammel et al found 
that the VTA DA neurons that project to the PFC, basolateral amygdala, and NAc are 
able to fire action potentials at a higher frequency (20-30 Hz) than those that project to 
the striatum (<10 Hz) (Lammel et al., 2008).  In addition, some PFC projecting DA 
neurons lack D2R autoinhibition and have low levels of DAT expression.  These factors 
likely contribute to the sustained pattern of DA release seen in the PFC. 
 
Functional implications of dopamine neuron heterogeneity 
 Prior to the last five years many studies of VTA DA neurons focused on DA 
neurons in lateral VTA areas while DA neurons in the medial VTA and A10dc areas 
were largely ignored. The few studies that have focused on medial DA neurons have 
shown interesting results. Lammel et al. show that only an aversive stimulus increases 
the AMPA/NMDA ratio of medial PBP and paranigral DA neurons projecting to the PFC, 
while the AMPA/NMDA ratio of traditional NAc projecting lateral VTA DA neurons is 
increased only by rewarding stimuli (Lammel et al., 2011). DA neurons of the A10dc 
areas, specifically those located in the PAG, are regulated by a variety of actions 
including acute ethanol, heroin reward, and the sleep-wake cycle (Flores et al., 2006; Li 
et al., 2013a; Lu et al., 2006). The A10dc and medial DA neurons of the RLi and CLi 
primarily project to the PFC, central nucleus of the amygdala (CeA), and the bed 
nucleus of the stria terminalis (BNST) (Deutch et al., 1991; Hasue and Shammah-
Lagnado, 2002; Lammel et al., 2008; Lammel et al., 2011). These downstream regions 
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are heavily involved in addiction and reward, as well as stress and anxiety related 
behaviors. There is some evidence that the DA neurons of the PAG play roles in alcohol 
and heroin reward. For example, depletion of RLi and PAG DA abolishes heroin 
conditioned place preference behavior in rats, and acute alcohol induces an 
enhancement of glutamatergic transmission and increases firing rate of vPAG DA 
neurons (Flores et al., 2006; Li et al., 2013a). However, there have been very few 
studies examining the roles of midline DA neurons in stress and anxiety.  
 
Sensitivity of the dopamine system to stress 
Stress may lead to pathological conditions such as anxiety disorders, depression, 
post-traumatic stress disorder (PTSD), and addiction, and stress is commonly stated as 
a cause of relapse for those suffering from drug addiction (Sareen et al., 2006; Sinha et 
al., 2011).  There is evidence that DA plays a role in the stress response; therefore, 
further examination of DA’s involvement in stress may lead to novel treatment pathways 
for stress-induced pathological conditions.  
 
Acute stress increases c-fos expression in a subset of dopamine neurons 
Stress may alter the activity of DA neurons, and one way of looking at this is 
through the expression of immediate early genes such as c-fos. Activation of immediate 
early genes represents metabolic activation or increases in the activity of a neuron. 
Following acute immobilization stress there is an increase in Fos immunoreactivity in 
areas positive for TH terminals in the rat CeA (Honkaniemi, 1992; Honkaniemi et al., 
1992). Other acute stressors, such as exposure to TMT, mild foot shock, and restraint, 
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lead to an increase in Fos immunoreactivity among DA neurons of the VTA, but not SN 
in rats (Deutch et al., 1991; Redmond et al., 2002). Deutch and colleagues determined 
that this stress-induced c-fos increase varies by VTA subregions, with the highest 
increases in the PBP and CLi, and that the majority of double labeled Fos and TH 
neurons project to the mPFC with few projecting to the NAc (Deutch et al., 1991). The 
CLi DA neurons heavily project to the BNST and CeA (Hasue and Shammah-Lagnado, 
2002), but this study did not determine whether the Fos labeled cells project to these 
regions of the extended amygdala. 
 
Alterations in dopamine concentration and metabolism 
Stress may also lead to changes in the DA levels and metabolism. For example, 
intermittent tail shock and foot shock stress increase extracellular DA levels in the 
striatum, NAc, and mPFC (Abercrombie et al., 1989; Kalivas and Duffy, 1995; Sutoo 
and Akiyama, 2002). Several acute stressors including immobilization, restraint, 
exposure to the predator odor TMT, and foot shock increase DA metabolism in 
downstream regions such as the mPFC, NAc shell, CeA, and BNST (Coco et al., 1992; 
Deutch et al., 1991; Morrow et al., 1997; Morrow et al., 2000). In contrast, chronic stress 
paradigms such as six days restraint stress or three weeks of restraint combined with 
unavoidable tail shock decrease the levels of DA and its metabolites in the NAc shell 
(Imperato et al., 1993; Mangiavacchi et al., 2001). Based upon the increase in c-fos 
expression and changes in DA levels in target regions, alterations in firing of DA 
neurons after acute stress exposure might be expected. 
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Alterations in the firing of dopamine neurons 
 There is some evidence that the firing of DA neurons is inhibited by aversive 
stimuli, such as foot shock, in anesthetized rats (Ungless et al., 2004). However, there 
are studies in which firing of putative DA neurons is enhanced with stress. In vivo 
electrophysiology recordings indicate that noxious tail pinch of the anesthetized rat 
selectively increases the firing rate of A10 DA neurons that innervate the PFC, but not 
DA neurons that project to the NAc (Mantz et al., 1989). One session of restraint stress 
in awake rats increases the number of spikes within a burst in VTA DA neurons that 
have a high level of basal bursting activity (Anstrom and Woodward, 2005). A single 
exposure to social defeat stress in rats also increases burst firing in VTA DA neurons 
and increases DA release in the NAc core (Anstrom et al., 2009). An increase in DA 
firing rate after acute stress correlates with previous data discussed highlighting 
increases in DA concentration and metabolism after acute stress. 
In contrast, rats that are subjected to chronic cold stress undergo a decrease in 
the number of spontaneously active DA cells compared to control animals (Moore et al., 
2001). The firing rate and percentage of spikes fired in bursts are not significantly 
altered from that of control animals. However, the distribution of bursting across VTA 
and SN DA neurons differs between the two groups. There is a population of DA 
neurons in the stressed animals that exhibit an extremely high bursting rate. The 
decrease in active DA cells with a chronic stressor correlates with data showing 
decreased levels of DA in target regions after chronic stress (Imperato et al., 1993; 
Mangiavacchi et al., 2001). These data suggest that chronic stress may inactivate one 
population of DA neurons while increasing burst activity in another. There is evidence 
18	  
	  
that populations of DA neurons possess the ability to switch from single spiking mode to 
burst firing mode (Cooper, 2002). These populations may represent DA neurons that 
project to different target regions, such as PFC, NAc, BNST or CeA. Different 
populations of DA neurons and their projection targets may mediate unique responses 
to stress, perhaps differing in sensitivity to stress or mediating the switch in response 
from acute to chronic stress. Since stress modifies the firing properties of some DA 
neurons and norepinephrine is a major stress neurotransmitter, it can be postulated that 
the actions of norepinephrine inputs may be partially responsible for the stress effects of 
DA.   
 
Norepinephrine 
 One system by which stress could regulate DA is the neurotransmitter 
norepinephrine (NE). Interactions of the NE and DA system contribute to the 
pathophysiology of schizophrenia, major depressive disorder, and ADHD, which is often 
comorbid with major depressive and anxiety disorders (El Mansari et al., 2010; Hensler 
et al., 2013; Sharma and Couture, 2014). First I will provide background on the anatomy 
and signaling of NE and then discuss known interactions of NE and DA. The NE system 
was first visualized and characterized in the early 1960s along with the dopamine 
system. The noradrenergic cell groups (A1-A7) are defined in Table 1. The ascending 
axons of A1 and A2 combine to form the ventral noradrenergic bundle, while the locus 
coeruleus (LC) forms the dorsal noradrenergic bundle. The LC has a broad projection 
field, and NE arising from the LC has been shown to play roles in arousal and cognitive 
performance (Aston-Jones and Cohen, 2005; Clayton et al., 2004). The non-LC NE 
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neurons are located in brainstem homeostatic centers and have been shown to be 
involved in a variety of processes. For example, A1 neurons control the release of 
vasopressin, A2 neurons are involved in regulation of food intake, and A5 neurons 
regulate the respiratory rhythm generator of the rostral ventrolateral medulla (Blessing 
and Willoughby, 1985; Hilaire et al., 2004; Rinaman, 2003). The role of NE in stress has 
been widely studied (Abercrombie et al., 1988; Cecchi et al., 2002a; Korf et al., 1973; 
Smagin et al., 1995; Valentino et al., 1993). Many stressors increase the firing of NE 
neurons and increase NE turnover in target regions (Abercrombie et al., 1988; Cecchi et 
al., 2002a; Cecchi et al., 2002b; Korf et al., 1973).  
 
Noradrenergic innervation of the dopamine system 
It has long been known that the LC projects to the VTA (Geisler and Zahm, 2005; 
Jones and Moore, 1977; Phillipson, 1979b; Simon et al., 1979). More recently, it was 
determined that there is a large non-LC noradrenergic innervation to DA regions. 
Through dopamine beta hydroxylase (DBH) immunohistochemistry and anatomical 
tracing studies, Mejías-Aponte found that the VTA DA nuclei receive noradrenergic 
innervation from A1, A2, A5 and LC (Mejias-Aponte et al., 2009). Out of the nuclei 
investigated, the medial aspects of the PBP and paranigral VTA nuclei receive the 
smallest proportions of noradrenergic efferents. The RLi and CLi have a larger overall 
NE input and a larger percentage of NE arising from non-LC sources, while the medial 
PBP and paranigral nuclei have a large proportion of NE input arising from LC (Mejias-
Aponte et al., 2009). There is also a noradrenergic input from the LC to the PAG, near 
the A10dc DA population (Lu et al., 2006). Electron microscopy studies have shown that 
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NE afferents have extrasynaptic and synaptic connections onto VTA DA neurons 
(Liprando et al., 2004). The abundant NE innervation makes the midbrain DA neurons 
prime candidates to undergo modulation by NE after stress. Furthermore, the varying 
noradrenergic input combined with differing outputs for distinct DA neuron populations 
indicates a possible differential sensitivity to stress among DA neuron populations. 
 
Noradrenergic receptors 
 Norepinephrine can act through nine different adrenergic receptors (ARs). These 
nine ARs are divided into three classes: α1-, α2-, and β-ARs.  Each class is further 
divided into the following subtypes: α1-ARs consist of α1A, α1B, and α1D; the α2-ARs are 
α2A, α2B, and α2C; and the β-ARs are β1, β2, and β3 (Bylund et al., 1994). Adrenergic 
receptors are GPCRs that can act to modulate synaptic transmission at either pre- or 
post-synaptic sites. α1-ARs signal through Gq mediated pathways, the α2-ARs are linked 
to Gi/o signaling, and the β-ARs signal through Gs mechanisms (Hein, 2006). There is 
some evidence of expression of the following ARs in the VTA: α1-ARs, α2C-ARs, and β1- 
and β2-ARs (Day et al., 1997; Greene et al., 2005; Jones et al., 1985; Lee et al., 1998; 
Rainbow et al., 1984).  
 
Noradrenergic modulation of dopamine neurons 
 
Alterations in the excitability of dopamine neurons 
 NE has been shown to bidirectionally modulate the firing of DA neurons. A series 
of in vivo studies done by Grenhoff and colleagues show that electrical stimulation of 
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the LC and administration of drugs acting on adrenergic receptors can alter DA neuron 
firing within the SN and VTA of rats (Grenhoff and Svensson, 1988; Grenhoff and 
Svensson, 1989; Grenhoff et al., 1993; Grenhoff and Svensson, 1993). These studies 
show that activation of the α1-AR leads to increased burst firing of VTA DA neurons, and 
burst firing can be increased or decreased with blockade or activation of α2-ARs, 
respectively. Ex vivo recordings in rat brain slices show that transient activation of α1-
ARs via iontophoresis leads to an outward current that would likely inhibit firing of VTA 
DA neurons while prolonged activation leads to an inward current that may make VTA 
DA neurons more excitable (Guiard et al., 2008a; Paladini and Williams, 2004). An LC 
selective lesion enhances the in vivo firing of VTA DA neurons, suggesting a net 
inhibitory role of LC-NE on VTA DA neurons (Guiard et al., 2008b). There is also 
evidence of adrenergic modulation of Ih, the hyperpolarization activated cation current, 
in putative VTA DA neurons in rat brain slices.  The activation of α2-ARs leads to an 
inhibition of Ih and inhibition of spontaneous firing in DA neurons	  that can be blocked by 
selective α2-AR antagonists (Inyushin et al., 2010). These results are in concordance 
with the Grenhoff studies, in which activation of α2-ARs lead to a decrease in firing rate 
in vivo. The role of NE on excitability of DA neurons may vary depending on the specific 
receptors activated and their site(s) of action, the length of agonist application, and the 
source of NE input. In general, activation of α1-ARs and α2-ARs leads to an increase 
and decrease, respectively, in the excitability of midbrain DA neurons. Further work 
needs to be done in this area to determine the mechanisms underlying NE modulation 
of DA neuron firing. One possibility is that NE may modulate synaptic transmission 
which then influences the firing of DA neurons.  
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Noradrenergic modulation of synaptic transmission onto dopamine neurons 
Norepinephrine is a powerful modulator of synaptic transmission in many brain 
regions, including the VTA. Since there are NE inputs in the VTA and evidence of 
multiple AR subtypes, it is possible that NE may modulate synaptic transmission onto 
DA neurons. Indeed, activation of α1-ARs decreases GABAergic transmission onto VTA 
DA neurons via a presynaptic mechanism (Velasquez-Martinez et al., 2015). Changes 
in GABAergic input on VTA DA neurons can control their firing patterns, and decreased 
GABAergic inhibition contributes to the generation of bursts in DA neurons (Lobb et al., 
2010; Morikawa and Paladini, 2011; Paladini et al., 1999; Paladini and Tepper, 1999). 
Stimulation of glutamate afferents facilitates the switch from pacemaker firing to burst 
firing in midbrain DA neurons (Harnett et al., 2009; Overton and Clark, 1992; Seutin et 
al., 1993). Therefore, modulation of glutamatergic transmission onto DA neurons by NE 
could have profound effects on firing of DA neurons and subsequently, the amount of 
DA released in target regions. 
 
The α1-AR is involved in many different physiological processes 
 The α1-AR is involved in the development of stress and anxiety responses, as 
well as addiction-related behaviors (Cecchi et al., 2002b; Greenwell et al., 2009; 
Jimenez-Rivera et al., 2006). In addition, stimulation of the α1-AR has numerous effects 
in the periphery and central nervous system. There are many examples of α1-ARs 
influencing GABAergic transmission. For example, in the piriform cortex and the CA1 
region of the hippocampus α1-AR activation leads to an excitation of interneurons 
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(Bergles et al., 1996; Hillman et al., 2009; Marek and Aghajanian, 1996). α1-AR 
mediated increases in inhibitory drive have been shown to occur in many brain regions 
such as the frontal, entorhinal and cerebellar cortices, basolateral amygdala, BNST, and 
medial septum (Alreja and Liu, 1996; Braga et al., 2004; Dumont and Williams, 2004; 
Herold et al., 2005; Kawaguchi and Shindou, 1998; Lei et al., 2007). In addition to the 
effects of α1-AR activation on GABAergic transmission, there are many examples of α1-
AR activation modulating glutamatergic transmission. In layer V of pyramidal cells of rat 
cortex, α1-AR activation causes a decrease in excitatory postsynaptic currents (EPSCs) 
through postsynaptic mechanisms (Kobayashi et al., 2009). Numerous studies indicate 
that α1-AR activation leads to long term depression (LTD) of excitatory transmission in 
several brain regions such as visual cortex, hippocampus, and BNST (Kirkwood et al., 
1999; McElligott and Winder, 2008; McElligott et al., 2010; Scheiderer et al., 2004; 
Scheiderer et al., 2008).  In contrast, there are also many studies indicating that α1-AR 
stimulation increases spontaneous EPSCs and/or miniature EPSCs in many brain 
regions including cultured hippocampal neurons, hypothalamus, mPFC, and prelimbic 
cortex (Aubert et al., 2001; Dong et al., 2005; Gordon and Bains, 2003; Gordon and 
Bains, 2005; Marek and Aghajanian, 1999).   
 In addition to their actions in the CNS, there are also many actions of α1-ARs in 
the periphery. α1-ARs mediate smooth muscle contraction which can result in 
vasoconstriction and hypertension (Piascik and Perez, 2001). In contrast, α1-ARs 
underlie relaxation of the smooth muscle in the gut. The α1-AR has a positive inotropic 
effect on the heart and can induce glycogenolysis and gluconeogenesis from adipose 
tissue (Purves, 2012). α1-AR agonists are commonly used to treat nasal congestion, 
24	  
	  
while α1-AR antagonists can be used to treat hypertension or benign prostrate 
hyperplasia (Lepor et al., 2012). 
 
Summary 
 In recent years, it has become apparent that dopamine neurons of the A10 group 
do not belong to one homogenous group. They differ in their basic electrophysiological 
properties and molecular expression profiles. For example, some DA neurons located in 
the medial VTA and other midline areas such as the PAG lack a robust Ih and have 
lower levels of D2R, DAT, VMAT2, and TH mRNA expression. Even though these 
unique populations of DA neurons have received attention in recent years, classical 
studies of VTA neurons largely ignore midline DA neurons.  In this dissertation, we will 
focus on the unique, understudied DA neurons of the RLi and A10dc regions. These 
midline DA neurons are activated by stress, receive a dense noradrenergic input, and 
comprise a large portion of the DA input to the extended amygdala, an area heavily 
involved in stress and anxiety related behaviors (Deutch et al., 1991; Hasue and 
Shammah-Lagnado, 2002; Mejias-Aponte et al., 2009; Meloni et al., 2006). The circuitry 
of these DA neurons makes them prime candidates for NE neuromodulation.  In the 
second chapter of this dissertation, I report retrograde tracing studies that identify sub-
regions of DA neurons that project to the dorsal BNST in a TH-eGFP reporter mouse 
line.  Then in the third chapter, the effects of NE on excitatory transmission onto DA 
neurons of the RLi in the TH-eGFP mouse are examined. 
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CHAPTER II 
 
A10dc dopamine neurons innervate the dorsal lateral bed nucleus of the stria 
terminalis 
 
Dopamine signaling is critically important in both acute and chronic responses to 
drugs of abuse. To date, most work has focused on the impact of drugs of abuse on 
dopamine neurons in the ventral tegmental area. However, an additional population of 
midline dopamine neurons in the periaqueductal grey and dorsal raphe, the A10dc, may 
play a critical role in addiction. These neurons are particularly interesting, as they 
project to several regions of the brain that regulate anxiety like behavior and stress 
responsivity. Since stress is the most frequent cause of relapse in previously addicted 
humans, we have begun to explore the anatomy of A10dc DA neurons in a mouse 
model, with the long term goal of understanding the role of these neurons in anxiety and 
addiction related behaviors. We used a transgenic mouse line that expresses eGFP 
under the control of the tyrosine hydroxylase promoter to visually identify DA neurons 
within the ventral tegmental area, rostral linear and caudal linear nuclei, ventral lateral 
periaqueductal grey, and dorsal raphe. Retrograde tracer was injected into the bed 
nucleus of the stria terminals, a region of the extended amygdala shown to be important 
in stress-induced reinstatement of drug-seeking. As shown previously in rats, both 
A10dc and ventral tegmental area DA neurons project to the dorsal BNST. The largest 
numbers of eGFP-expressing neurons labeled with tracer were found in the ventral 
tegmental area, rostral linear nucleus, and A10dc group, located in the caudal portion of 
the dorsal raphe and adjacent ventral periaqueductal grey.  
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Introduction 
In human drug abusers, a major hurdle for successful long-term rehabilitation has 
been relapse of drug use even after a drug-free period of many years. Of the many 
reasons for relapse, stress has been cited as a primary cause (Erb, 2010; Sinha et al., 
2011). Brain networks that are active during stress responses include interconnected 
parts of the prefrontal cortex, extended amygdala, ventral tegmental area (VTA), 
hypothalamus, and brainstem areas such as the periaqueductal grey and 
norepinephrine containing nuclei. In particular, the bed nucleus of the stria terminalis 
(BNST) within the extended amygdala and the VTA, have been shown to be critical for 
relapse of drug-seeking behavior (Briand et al., 2010; Erb, 2010). Therefore 
investigations of the BNST and its immediate network partners may lead to therapeutic 
targets for breaking the cycle of drug addiction that rules the lives of susceptible 
individuals.  
In order to design rational therapies for prevention to relapse, a clearer 
understanding of the cellular and molecular events that underlie changes in how 
network partners communicate at each stage of the addiction cycle is needed. VTA DA 
(A10) neuron activity patterns have been shown to encode reward error information 
(Tobler et al., 2005) and a single cocaine injection is sufficient to cause a long-term 
increase in the AMPA/NMDA receptor ratio at glutamatergic synapses onto VTA DA 
neurons (Borgland et al., 2004; Kauer and Malenka, 2007). The DA released at 
synapses in several brain areas controls synaptic plasticity that plays important roles in 
the behavioral effects of drugs of abuse (Thomas et al., 2001). For example, in the 
BNST DA enhances spontaneous glutamatergic transmission (Kash et al., 2008) and 
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decreases evoked glutamatergic and inhibitory transmission (Krawczyk et al., 2011a; 
Krawczyk et al., 2011b). In addition, DA mediates a form of long term potentiation at 
BNST GABA synapses (Krawczyk et al., 2013), decreases BNST NMDA currents in 
cocaine self-administering rats (Krawczyk et al., 2014), and regulates long-term intrinsic 
excitability of BNST neurons (Francesconi et al., 2009).  The BNST receives some of its 
DA afferents from the VTA. However, anatomical studies in rats show that about half of 
the DA neurons that project to the BNST are in the dorsal-caudal extension of the A10 
DA neurons, called the A10dc cell group, which is located in the dorsal, rostral linear 
and central linear raphe nuclei (Hasue and Shammah-Lagnado, 2002; Zahm et al., 
2001). Importantly, these brainstem nuclei have been shown to be involved in the relay 
of visceral stress information as well as anxiety and pain (Meloni et al., 2006; Walker 
and Davis, 2008). Also, a small but potentially significant DA input to the BNST has 
been shown to originate from the ventral lateral periaqueductal grey (vlPAG) in rats 
(Meloni et al., 2006). The DA neurons of the RLi and vlPAG are involved in the 
rewarding properties of heroin (Flores et al., 2006).  
In recent years, an appreciation of the heterogeneity of DA neurons has arisen. It 
has been shown that DA neurons have different molecular expression profiles and 
electrophysiology properties based on their projection targets (Lammel et al., 2008; 
Margolis et al., 2008). Modulation of AMPA/NMDA ratios of A10 DA neurons in 
response to rewarding or aversive stimuli varies by their projection target (Lammel et 
al., 2011). In fact, DA neurons that project to the nucleus accumbens medial shell are 
modified by a cocaine injection while those that project to the PFC only respond to an 
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aversive stimulus (Lammel et al., 2011). While there has been much recent work in this 
area, none of these studies examine DA neurons that project specifically to the BNST. 
In this study, we sought to identify sub-regions of DA neurons that project to the 
mouse dorsal BNST. In addition we utilized a TH-eGFP transgenic reporter mouse to 
confirm the fidelity of eGFP in populations that project to the BNST. These studies will 
be crucial for guiding future electrophysiology studies investigating subpopulations of 
DA neurons that project to the BNST, as in Chapter III. 
 
Methods 
 
Animals 
Male mice ages 7-10 weeks were used in these experiments in accordance with 
animal use protocol approved by the Institutional Animal Care and Use Committee of 
Vanderbilt University. All experiments were carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals (NIH, 
Publications 864-23). Mice were group housed in the Vanderbilt vivarium with free 
access to food and water under a 12/12 hour light/dark cycle. C57BL/6J mice were used 
for the initial identification of brain areas with TH+ neurons that project to the BNST. 
Subsequent retrograde tracer and neuron count data were obtained from a TH-eGFP 
BAC transgenic mouse line (Strain Name: STOCK Tg(Th-EGFP)DJ76Gsat/Mmnc). 
Mating pairs of mice were from the Mutant Mouse Regional Resource Center in North 
Carolina. In this mouse line, the genome was modified to contain multiple copies of a 
modified BAC in which an eGFP reporter gene was inserted immediately upstream of 
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the coding sequence of the gene for tyrosine hydroxylase. Data presented here were 
obtained from a lineage of transgenic mice maintained in-house derived by cross-
breeding with Swiss Webster mice (Taconic). 
 
Stereotaxic surgeries and tracer injections 
7-10 week old mice were anesthetized with Isoflurane and secured in a 
stereotaxic apparatus (MyNeuroLab, Angle 2). The skull above the BNST was exposed 
and a small hole drilled through the bone. A glass micropipette with a tip diameter of 
approximately 30 µm was back-filled with a 3% solution of the retrograde tracer, 
fluorogold (FG), dissolved in cacodylate buffer (0.1 M, pH 7.0), and then inserted into 
the BNST. FG was microiontophoresed into the BNST with +1.5 µA in a 7 sec on/7 sec 
off cycle that lasted for 8 minutes. Ten minutes later, the pipette was withdrawn and the 
scalp wound was sutured closed. After recovery from the anesthesia, mice were 
returned to their home cage and given buprenorphin analgesic at 0.1 mg/kg, sc., every 
12 hours for 4 days. At 8 days post injection, mice were overdosed with Nembutal (100 
mg/kg, i.p.) for harvesting of brain tissue. 
 
Immunohistochemistry and microscopy 
Mice were transcardially perfused with ice–cold phosphate-buffered saline (PBS), 
followed by ice-cold 4% paraformaldehyde in PBS. Brains were removed from the skull 
and post-fixed in the same fixative overnight at 4°C and were then transferred to 30% 
sucrose in PBS. Two to five days later, 50 µm thick coronal or 100 µm sagittal sections 
of brain were sliced on a cryostat (Leica CM3050S). Free-floating sections were washed 
30	  
	  
in PBS (4x10 minutes), permeabilized with 0.5% Triton-X 100 in PBS, and then blocked 
with 10% normal donkey serum in PBS containing 0.1% Triton-X-100. Sections were 
then incubated with primary antibody in blocking solution for 48 hours at 4°C, followed 
by PBS washes (4x10 minutes) and incubation with cyanine dye-conjugated secondary 
antibodies for 24 hours at 4°C in PBS with 0.1% Triton-X-100. Finally, sections were 
washed (4x10 minutes), mounted on slides, sealed with PolyAquamount, and left 
overnight to dry. Stained sections were examined with a Zeiss 510 scanning confocal 
microscope. Z stacks of images were taken of every other sagittal section through the 
medial/lateral extent of the PAG or every 3rd coronal section through the rostral/caudal 
extent of the PAG and dorsal raphe nucleus (Franklin and Paxinos, 1997). Some FG 
injection site sections were imaged without immunohistochemistry, using intrinsic 
fluorescence induced by a 405 nm laser on a FV1000 Olympus confocal scanning 
microscope. Other injection site sections and all brainstem sections examined for 
retrograde labeled neurons were processed for immuno-staining for FG. Stained and 
unstained injection site sections gave similar results as to location and spread of FG. 
Control sections from wild type mice injected with FG and immuno-stained for FG 
showed only background fluorescence when imaged with eGFP channel settings, 
suggesting that after immuno-staining, native fluorescence of FG did not contribute to 
the eGFP signal. 
 
Reagents 
Fluorogold was obtained from Fluorochrome, mouse monoclonal anti-TH 
antibody from ImmunoStar (used at 1:2000 dilution), and rabbit polyclonal anti-
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fluorogold antibody from Chemicon (used at 1:3000 dilution). Secondary antibodies 
were purchased from Jackson ImmunoResearch and included Cy5-conjugated donkey 
anti-mouse (1:500), and Cy3-conjugated donkey anti-rabbit (1:500) FAB fragments. 
 
Data analysis 
TH-positive neurons in these brain areas have been previously shown to be 
dopamine beta hydroxylase negative and therefore dopaminergic (Flores et al., 2006; 
Lein et al., 2007). A10dc DA neurons are distributed within several areas including the 
dorsal, rostral linear and central linear raphe nuclei, the medial part of the vlPAG which 
contains small DA neurons, and in other parts of the PAG adjacent to the aqueduct. For 
counting single and multiple labeled neurons, z stacks of imaged brain sections were 
projected onto a single plane using Zeiss LSM software. Projected images were then 
opened in Metamorph and neurons counted with the help of a manual logger function. 
The signal intensity threshold for counting neurons as positive for a marker was set at 
twice that of the brightest neurons in no primary antibody control sections (TH and FG), 
or for eGFP, neurons in brainstem areas that did not express eGFP. In order to reduce 
bias, random groups of 3-5 sections from each animal were counted by 2 or 3 different 
investigators to be sure that the number of neurons in each category did not vary more 
than 10% between investigators. Although formal stereological methods were not 
employed in counting labeled neurons, we are satisfied that the level of precision 
obtained by our chosen method is sufficient to accurately detect the location of labeled 
neurons needed to direct targeted electrophysiological recordings from subpopulations 
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of DA neurons that likely project to the dBNST. Quantitative data are expressed as 
mean ± S.E.M. unless otherwise noted.  
 
Results 
 
Preliminary identification of TH-positive BNST afferents 
Wild-type C57BL/6J adult male mice were used for initial unilateral injections of 
FG into the dBNST. Two mice with tracer confined to the target region were serial-
sectioned in the sagittal plane and stained for FG and TH. The injection site of an 
example mouse is shown in Figure 2. The spread of FG was confined to the dBNST in 
the medial/lateral and rostral/caudal directions. In this example mouse and others in this 
study, FG also spread in the rostral direction to include the transition zone between the 
dBNST and the nucleus accumbens (Franklin and Paxinos, 1997; AP level 0.62 mm to 
Bregma). In mice where the injection site missed the BNST (with FG injections into the 
striatum only or the rostral globus pallidus lateral or dorsal to the dBNST, n=4) there 
were at most one or two FG positive/eGFP positive neurons in the A10dc. As expected, 
striatal injections labeled large numbers of A9 eGFP positive neurons (data not shown).  
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Figure 2: Example of a fluorogold injection into the dorsal BNST of a mouse.  
(A) Diagram of coronal brain section from Franklin & Paxinos mouse atlas showing 
location of the dorsal BNST. (B) results of an iontophoretic injection of fluorogold 
into the dorsal BNST. Fluorogold fluorescence is seen here without 
immunohistochemical staining. Data obtained by Dr. Robert Matthews 
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A brain atlas diagram of a parasagittal section that shows the nuclei of interest near the 
midline is shown in Figure 3A, and Figure 3B is a corresponding stained section from 
the same mouse as shown in Figure 2. The stained section shows the extent of the 
continuum of TH-positive neurons, including near midline A10, A10c, A10dc, and PAG 
neurons, plus neurons containing FG that project to the dBNST. In particular, single 
labeled and double labeled neurons were found throughout the extent of the DA neuron 
continuum. Three sub-regions appeared to be especially rich in double-labeled neurons, 
the VTA, the RLi and the caudal part of the DR (Figure 3B inset; see Figure 6 for cell 
counts). 
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Figure 3: Retrograde tracer data showing that a subset of TH positive 
brainstem neurons project to the dorsal BNST.  
(A) Diagram of a sagittal brain section from Franklin & Paxinos mouse atlas. (B) 
Example section of wild-type mouse brain injected with FG into the dBNST, taken 
from a medial/lateral coordinate closely matching the diagram in A. TH+ neurons are 
green and FG+ neurons are red. Inset: higher magnification view of the caudal part of 
the ventral PAG and dorsal raphe nucleus. Yellow/orange neurons are double 
labeled for FG and TH. Scale bar = 1 mm. Data obtained by Dr. Robert Matthews 
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Distribution of eGFP-expressing dopamine neurons that project to the dBNST 
FG was injected into the dBNST of transgenic mice (n=6) expressing eGFP 
under control of the TH promoter. Using our preliminary experiments in wild type mice 
as a guide, serial coronal sections were cut throughout the rostral/caudal length of the 
DA neuron continuum of sub-nuclei where FG positive neurons were also observed. 
Every third section was processed for immuno-staining for FG and TH, and the numbers 
of eGFP+, TH+, FG+, double labeled and triple labeled neurons were counted in images 
captured from each section with a 20x lens. Figure 4 shows typical sections used for 
cell counting at the level of the caudal dorsal raphe (A,B) and about the middle of the 
RLi (C,D). For cell counts, multicolor images were examined as separate images of 
each fluorophore, and as overlapping pairs of fluorophores. Figure 5 shows a series of 
higher magnification images taken of the dorsal raphe nucleus of one mouse at AP=4.3 
mm, centered approximately 100 µm ventral to the aqueduct. These images show the 
color of single, double or triple labeled neurons that were used in neuron counts. In 
order to address the questions of fidelity of eGFP expression within A10dc DA neurons, 
we counted TH+ neurons, eGFP+ neurons, and neurons with both markers from the RLi 
to the caudal end of the cerebral aqueduct. The percentage of TH+ neurons that were 
eGFP+ ranged from 41 to 82% and varied little along the rostral/caudal axis (62.9 ± 2.0 
%, n=3 mice, 8 sections per animal), suggesting substantial but incomplete labeling of 
DA neurons by transgenic expression of eGFP in this mouse line. When fidelity of eGFP 
expression to catecholaminergic neurons only was assessed for the A10dc brain region, 
the number of eGFP neurons that were TH+ showed a gradient along the rostral/caudal 
axis. Fidelity was highest in rostral sections (93.1 ± 1.6% at AP= -3.5; n=3 mice), slightly 
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lower at the level of the PAG/DR enriched in cells that project to the BNST (Figure 6) 
(75.8 ± 2.1% at = -4.2; n=3 mice) and less than 50% at AP levels more caudal than AP= 
-4.6 (39.2 ± 2.7%). These data suggest that eGFP fluorescence in this mouse line is a 
good although imperfect marker for A10dc DA neurons throughout most of its 
rostral/caudal extent. Neurons that were triple labeled, that is TH positive, DA neurons 
expressing eGFP that project to the dBNST, were most abundant approximately 4.2 mm 
posterior to Bregma with a smaller peak of abundance at about 3.5 mm posterior to 
Bregma. At these coordinates, triple labeled neurons constituted 21.5% and 17.5% of all 
eGFP neurons, respectively. Most triple labeled neurons had relatively small soma, in 
agreement with findings in rats (Hasue and Shammah-Lagnado, 2002; Meloni et al., 
2006). A summary graph of neuron counts for three mice whose injection sites had FG 
confined to the dBNST is shown in Figure 6. Three additional mice with spread of FG 
beyond the dBNST, laterally into the internal capsule, globus pallidus, and medial 
striatum had the same pattern and similar neuron counts in the A10dc/PAG areas but in 
addition had substantial numbers of double and triple labeled neurons in the substantia 
nigra (data not shown). 
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Figure 4: Examples of retrograde tracer data showing coronal sections from dorsal 
BNST-injected, TH-eGFP transgenic mice.  
(A&C) Brain atlas diagrams showing structures of interest and the regions (red boxes) 
selected for imaging and counting labeled neurons. (B&D) Corresponding confocal images 
(projections of z-stacks from 50 µm thick brain sections) of the regions in A & B. Blue = TH: 
green = eGFP; red = FG; purple = TH & FG; orange = eGFP & FG; aqua = TH & eGFP; 
scale bar = 50 um, applies to C & D. See Figure 5 for high magnification images and Figure 
6 for cell counts. Data obtained by Dr. Robert Matthews 
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Figure 5: High magnification confocal images of dorsal raphe neurons 
from projections of a subset (20 µm thick) of confocal microscope images.  
(A-C). Examples of labeled neurons for TH (blue), FG (red) and eGFP (green). 
(D-F) Overlay images showing examples of double labeled neurons, TH & 
eGFP, FG & eGFP and FG & TH, respectively. (G) Overlay image showing all 
three markers. Dotted vertical arrows indicate a neuron showing TH and FG 
only. Horizontal thin arrows indicate a neuron showing FG and eGFP only. 
Diagonal thick arrows indicate a triple labeled neuron. This section also contains 
singly labeled neurons for each marker (not indicated). Scale bar equals 20 µm. 
Data obtained by Dr. Robert Matthews 
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Figure 6: Plot of the number of labeled neurons counted in skip serial coronal 
sections from transgenic mice with unilateral injections of FG into the dBNST.  
Symbols represent the mean ± S.E.M., n=3. Data obtained by Dr. Robert Matthews 
41	  
	  
Discussion 
The BNST has been subdivided into multiple regions along the anterior/posterior, 
medial/lateral and dorsal/ventral dimensions (Dong et al., 2000; Dong et al., 2001; Dong 
and Swanson, 2003). The anterior dorsal lateral region (dlBNST) is composed of 
several sub-nuclei (Ju and Swanson, 1989) that are involved in relapse of drug seeking 
behavior in response to stress in rodent models of drug addiction (Briand et al., 2010). 
The dBNST receives most of the DA innervation of the BNST with a gradation of fiber 
density that is highest in the medial dBNST (Alheid et al., 1998). We and others have 
shown that DA is involved in regulating corticotropin releasing factor (CRF) and 
glutamate dependent signaling in the BNST and therefore the DA afferents to the BNST 
likely encode information relevant to drug addiction related behaviors (Francesconi et 
al., 2009; Kash et al., 2008). 
VTA DA neurons have been extensively studied, their electrophysiological 
properties, propensity for burst or pacemaker-like firing patterns, and the correlation of 
firing with reward and reward-related cues are known (Grace and Onn, 1989; Grace et 
al., 2007; Lammel et al., 2008; Margolis et al., 2006; Tobler et al., 2005). All drugs of 
abuse are known to increase dopaminergic neurotransmission and some have been 
shown to cause long-term changes in the VTA (Saal et al., 2003). In contrast to VTA DA 
neurons, A10dc and PAG DA neurons have not been extensively characterized, nor is it 
known if drugs of abuse have effects on glutamatergic synapses on identified DA 
neurons in these brain areas. Since the midline raphe/PAG areas are known to mediate 
reactions to stress, anxiety, and pain (Meloni et al., 2006), A10dc DA neurons are in a 
key position to report information to the dBNST that would combine with reward related 
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signals from VTA DA neurons and contribute to stress-induced relapse. Data presented 
here can be used as a guide for creating ex vivo brain slice preparations from TH-eGFP 
transgenic mice in order to record from DA neurons in sub-regions of the A10dc group 
that project to the dBNST. Questions can then be addressed as to how acute and 
chronic exposures to drugs of abuse affect synaptic transmission in these DA neuron 
nuclei as compared to the VTA. 
In summary, we have shown that the A10dc neurons in mice contribute a large 
portion of the DA neurons that project to the dBNST and are easily identified in brain 
slice preparations from a transgenic mouse line that expresses eGFP in a subset of 
TH+ neurons. In particular, the caudal part of the dorsal raphe nucleus and the rostral 
linear raphe nucleus contain most of the DA afferent neurons that are found outside of 
the VTA and project to the BNST. These data agree with previously published data from 
rats. Selective recording from eGFP+ neurons from these mice will contribute to the 
understanding of their role in addiction related behaviors. 
 
Anatomical Caveats 
 We would like to address the issue regarding the difficulty of delineating 
boundaries between the dopaminergic regions of the RLi, CLi, vPAG, and DR. The DA 
neurons in these regions are not delineated with clear boundaries and it is therefore 
difficult to distinguish regions for cell counts.  This reason is the basis for our 
representation of cell counts in Figure 6 in terms of distance from Bregma rather than 
anatomical divisions. The anatomical descriptions of the data in this section were based 
on our interpretation of Hökfelt (Hokfelt et al., 1984) and the Paxinos and Watson 
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mouse brain atlas and we recognize that our interpretations are not without error . 
However, the results of these retrograde tracer studies coincide with published studies 
in the rat (Del-Fava et al., 2007; Hasue and Shammah-Lagnado, 2002; Meloni et al., 
2006). The studies in Chapter II provide a guide for our electrophysiology studies in 
Chapter III in which we record from midline DA neurons in RLi areas that project to the 
BNST, have high stress-induced Zif268 expression (Figures 15-16), and have high 
fidelity in our TH-eGFP (Figure 7) BAC transgenic mouse. 
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CHAPTER III 
 
Excitatory drive onto dopaminergic neurons in the rostral linear nucleus is 
enhanced by norepinephrine in an α1 adrenergic receptor-dependent manner 
 
Dopaminergic innervation of the extended amygdala regulates anxiety-like 
behavior and stress responsivity. A portion of this dopamine input arises from dopamine 
neurons located in the ventral lateral periaqueductal gray (vlPAG) and rostral (RLi) and 
caudal linear nuclei of the raphe (CLi). These regions receive substantial 
norepinephrine input, which may prime them for involvement in stress responses. Using 
a mouse line that expresses eGFP under control of the tyrosine hydroxylase promoter, 
we explored the physiology and responsiveness to norepinephrine of these neurons. 
We find that RLi dopamine neurons differ from other VTA dopamine neurons with 
respect to membrane resistance, capacitance and the hyperpolarization-activated 
current, Ih. Further, we found that norepinephrine increased the frequency of 
spontaneous excitatory postsynaptic currents (sEPSCs) on RLi dopamine neurons. This 
effect was mediated through the α1 adrenergic receptor (AR), as the actions of 
norepinephrine were mimicked by the α1-AR agonist methoxamine and blocked by the 
α1-AR antagonist prazosin. This action of norepinephrine on sEPSCs was transient and 
not a form of synaptic plasticity, as it did not persist following the subsequent application 
of prazosin. Methoxamine also increased the frequency of miniature EPSCs, indicating 
that the α1-AR action on glutamatergic transmission likely has a presynaptic 
mechanism. There was also a modest decrease in sEPSC frequency with the 
application of the α2-AR agonist UK-14,304. These studies illustrate a potential 
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mechanism through which norepinephrine could recruit the activity of this population of 
dopaminergic neurons. 
 
Introduction 
Addiction exhibits significant comorbidity with mood and anxiety disorders, and 
stress is frequently stated as a cause for drug use relapse (Sareen et al., 2006; Sinha et 
al., 2011). The extended amygdala, which contains the bed nucleus of the stria 
terminalis (BNST) and the central nucleus of the amygdala (CeA), has been shown to 
play an important role in stress, anxiety, and addiction related behaviors (Davis et al., 
2010; Erb, 2010; Koob, 2009). Dopaminergic afferents in the extended amygdala are 
thought to regulate anxiety-like behavior and stress responsivity (Meloni et al., 2006). 
While dopamine is classically regarded as a “reward” neurotransmitter, the firing of 
dopamine neurons increases following acute stress, and dopamine has also been 
proposed to encode aspects of aversive stimuli (Anstrom and Woodward, 2005; 
Anstrom et al., 2009; Brischoux et al., 2009; Coco et al., 1992; Deutch et al., 1991; 
Lammel et al., 2011; Matsumoto and Hikosaka, 2009). However, the impact of the 
midbrain dopamine system’s sensitivity to stress is not well understood and requires 
further investigation. 
Dopamine release in the extended amygdala has several actions. For example, 
in the CeA and BNST dopamine enhances spontaneous glutamatergic transmission 
(Kash et al., 2008; Silberman and Winder, 2013). In the BNST, dopamine decreases 
evoked glutamatergic and inhibitory transmission (Krawczyk et al., 2011a; Krawczyk et 
al., 2011b), mediates a form of long term potentiation at GABA synapses (Krawczyk et 
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al., 2013), decreases NMDA currents in cocaine self-administering rats (Krawczyk et al., 
2014), and regulates long-term intrinsic excitability of BNST neurons (Francesconi et al., 
2009). The BNST receives a substantial proportion of its total dopaminergic input from 
the ventral lateral periaqueductal grey (vlPAG) and the dorsal-caudal extension of the 
A10 dopamine cell group of the ventral tegmental area (VTA), termed the A10dc cell 
group, which is located in the dorsal, rostral linear (RLi), and caudal linear raphe nuclei 
(CLi) (Hasue and Shammah-Lagnado, 2002; Meloni et al., 2006). The dopamine 
neurons of the lateral VTA have been extensively studied while those of the A10dc 
group have often been overlooked. While overall very little is known about A10dc roles 
and properties, evidence suggests that the RLi is particularly sensitive to stressors 
(Deutch et al., 1991).   
There is an increasing appreciation regarding the functional heterogeneity of 
dopamine neurons. Electrophysiological properties of dopamine neurons, such as 
action potential width and the presence of a hyperpolarization-activated current (Ih), 
differ based on their projection targets and anatomical location (Lammel et al., 2011; Li 
et al., 2013a; Margolis et al., 2008). The modulation of excitatory synapses on 
dopamine neurons by aversive and rewarding stimuli also depend on their projection 
targets (Lammel et al., 2011). For example, the dopamine neurons located in the medial 
posterior VTA, near the RLi, have no Ih and their glutamatergic synapses are modified 
by aversive, but not rewarding stimuli (Lammel et al., 2011). Therefore, study of the 
basal electrophysiological properties of RLi dopamine neurons may give early insights 
into their actions. 
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 The noradrenergic system is a key regulator of the stress response. Many 
stressors increase the firing of norepinephrine neurons and increase norepinephrine 
turnover in target regions (Abercrombie et al., 1988; Cecchi et al., 2002b; Korf et al., 
1973). The locus coeruleus, A1, A2, and A5 norepinephrine groups send efferents to 
the RLi (Mejias-Aponte et al., 2009).  Activation of α1 or α2 adrenergic receptors (ARs) 
induce changes in burst firing of VTA dopamine neurons, (Grenhoff and Svensson, 
1989; Grenhoff et al., 1993; Grenhoff and Svensson, 1993; Guiard et al., 2008a) and 
glutamatergic transmission is crucial for burst firing of dopamine neurons (Overton and 
Clark, 1992; Seutin et al., 1993). Norepinephrine acts as a powerful modulator of 
excitatory neurotransmission in many limbic brain areas. Activation of β, α1, and α2-ARs 
have been shown to enhance or attenuate glutamatergic transmission in a variety of 
brain regions, including the hippocampus, CeA, BNST and VTA (Egli et al., 2005; Flavin 
and Winder, 2013; Gereau and Conn, 1994; Jimenez-Rivera et al., 2012; McElligott and 
Winder, 2008; McElligott et al., 2010; Nobis et al., 2011; Shields et al., 2009; 
Velasquez-Martinez et al., 2012). Therefore, norepinephrine might modulate 
glutamatergic transmission on RLi dopamine neurons.   
 Given the interconnections of the RLi with circuitry mediating stress and anxiety 
and the stress sensitivity of RLi dopamine neurons, it is important to investigate the 
actions of norepinephrine on RLi dopamine neurons. Using a tyrosine hydroxylase (TH)-
eGFP reporter mouse line, we found differences in basal electrophysiological 
properties, such as Ih, membrane resistance and capacitance, of VTA and RLi 
dopamine neurons. We also investigated the actions of norepinephrine on spontaneous 
glutamatergic transmission and found an increase in the frequency of spontaneous 
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excitatory postsynaptic currents (sEPSCs) on RLi dopamine neurons. Through the 
application of specific AR agonists and antagonists, we determined that this 
enhancement of excitatory transmission is due to the activation of α1-ARs. α1-ARs also 
increased the frequency of miniature EPSCs indicating a potential presynaptic locus for 
this modulation. In addition to this large α1-AR mediated enhancement of excitatory 
transmission, we also found a modest α2-AR mediated depression of excitatory 
transmission in RLi dopamine neurons. 
 
Methods 
Animals 
Male mice ages 3-5 weeks were used in these experiments in accordance with 
animal use protocol approved by the Institutional Animal Care and Use Committee of 
Vanderbilt University. All experiments were carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals (NIH 
Publications No. 8023). Mice were group housed in the Vanderbilt vivarium under a 12 
hour light/dark cycle with food and water ad libitum. All mice were obtained from a 
transgenic mouse line (Strain Name: STOCK Tg(Th-EGFP)DJ76Gsat/Mmnc). Mating 
pairs of mice were initially obtained from the Mutant Mouse Regional Resource Center 
in North Carolina. In this mouse line, the genome was modified to contain multiple 
copies of a modified BAC in which an eGFP reporter gene was inserted immediately 
upstream of the coding sequence of the gene for TH. Data presented here were 
obtained from two lineages of transgenic mice maintained in-house, one derived by 
cross-breeding with Swiss Webster mice (Taconic), and the other by cross-breeding 
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with C57/B6 mice (Jackson Laboratories). The characterization of basal 
electrophysiology properties was performed in mice with the Swiss Webster 
background. The remainder of the electrophysiology studies and the 
immunohistochemistry were performed in TH-eGFP mice that were backcrossed with 
C57/B6 mice for many generations.   
 
Immunohistochemistry and microscopy 
Mice were transcardially perfused with ice-cold phosphate-buffered saline (PBS), 
followed by ice-cold 4% paraformaldehyde in PBS. Brains were removed from the skull 
and post-fixed in the same fixative overnight at 4oC, and were then transferred to 30% 
sucrose in PBS. Two to five days later, 40 µm thick coronal sections of brain were sliced 
on a cryostat (Leica CM3050S). Free-floating sections were washed in PBS (4x10 
minutes), permeabilized with 0.5% Triton-X 100 in PBS, and then blocked with 10% 
normal donkey serum in PBS containing 0.1% Triton-X 100. Sections were then 
incubated with a mouse monoclonal anti-TH antibody (from ImmunoStar used at 1:2000 
dilution) in blocking solution for 48 hours at 4oC, followed by PBS washes (4x10 
minutes) and incubated with a Cy3-conjugated donkey anti-mouse secondary antibody 
(from Jackson ImmunoResearch used at 1:500 dilution) for 24 hours at 4oC in PBS with 
0.1% Triton-X 100. Finally, sections were washed (4x10 minutes), mounted on slides, 
sealed with PolyAquamount, and left overnight to dry. Stained sections were examined 
with a Zeiss 510 scanning confocal microscope.   
 
Electrophysiology recordings 
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3-5 week old TH-eGFP mice were decapitated under Isoflurane anesthesia. The 
brains were quickly removed and placed in oxygenated ice-cold sucrose artificial 
cerebrospinal fluid (ACSF): 194 mM sucrose, 20 mM NaCl, 4.4 mM KCl, 2 mM CaCl2, 1 
mM MgCl2, 1.2 mM NaH2PO4, 10 mM glucose, and 26 mM NaHCO3. Three-hundred µm 
coronal slices of the VTA or RLi were prepared using a vibrating microtome (Leica VT 
1200). Two RLi slices per mouse were generated. Slices were incubated for 1 hour in 
oxygenated ACSF at 28oC: 124 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl2, 2 mM Mg2SO4, 
1.25 mM NaH2PO4, 11 mM glucose, 26 mM NaHCO3, and 0.4mM ascorbic acid. Slices 
then rested in a submerged superfusion chamber (Warner Instruments) for 30 minutes 
prior to recordings. 
The TH-eGFP positive neurons were identified via fluorescent microscopy, and 
directly visualized with infrared video microscopy (Olympus) for patching. Recording 
electrodes were fabricated with a Flaming-Brown Micropipette Puller (Sutter 
Instruments) using thin-walled borosilicate glass capillaries (World Precision 
Instruments). Recording electrodes of resistance 2.5-5.5 MΩ were filled with an internal 
solution of 290-295 mOsmol, pH = 7.2-7.3, consisting of: 125 mM K+-gluconate, 5 mM 
NaCl, 4.4 mM KCl, 10 mM HEPES, 0.6 mM EGTA, 4 mM ATP, and 0.4 mM GTP for Ih 
current recordings and 117 mM Cs+-gluconate, 20 mM HEPES, 0.4 mM EGTA, 5mM 
TEA, 2mM MgCl2, 4 mM ATP, and 0.3 mM GTP for the remainder of the 
electrophysiology recordings. All electrophysiology recordings were made using 
Clampex 9.2 and analyzed using Clampfit 10.2 (Molecular Devices). Ih currents were 
measured in the voltage-clamp recording configuration by stepping the holding potential 
from -60mV to -120mV for 1 second and then measuring the difference between the 
51	  
	  
current immediately following the step to -120mV and the current at the end of the -
120mV step. Whole-cell, voltage-clamp recordings were performed as described 
previously (Egli et al., 2005; Kash et al., 2008; Nobis et al., 2011; Silberman and 
Winder, 2013). Briefly, AMPA receptor-mediated sEPSCs were made at −70 mV and 
pharmacologically isolated by the addition of 25 µM picrotoxin to the ACSF. Cells were 
allowed to equilibrate to whole-cell configuration for 5 min before recordings began. 
sEPSC recordings were acquired and analyzed in 2 min gap-free blocks, and access 
resistance was monitored between blocks of sEPSC recordings. Those experiments in 
which the access resistance changed by >20% were not included in the data analyses. 
For the experiment in which the effect of prazosin was determined, the antagonist was 
pre-applied for at least 15 minutes before application of norepinephrine and then 
remained onboard for the duration of the experiment. To isolate miniature EPSCs 
(mEPSCs) 1 uM tetrodotoxin (TTX) was added in addition to sEPSC recording 
conditions. 
 
Data analysis 
For counting single and multiply labeled neurons, z stacks of imaged brain 
sections were projected onto a single plane using Zeiss LSM software. Projected 
images were then opened in Metamorph and neurons counted with the help of manual 
logger functions. The signal intensity threshold for counting neurons as positive for a 
marker was set at twice that to the brightest neurons in no primary antibody control 
sections (TH), or for eGFP, neurons in brainstem areas that did not express eGFP. 
Quantitative data are expressed as mean ± S.E.M. unless otherwise noted. 
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For electrophysiology studies, statistical analyses were performed using 
Microsoft Excel 2010 and GraphPad Prism 6. Specifically, when comparisons were 
made between RLi and VTA basal excitability properties, an unpaired Student’s t-test 
was used. When determining whether a compound had a significant effect, a Student's 
paired t-test was used, comparing the baseline value to the peak experimental value. 
Paired comparisons were made between baseline (the average of the last three 
recording blocks before drug is added) and the three recording blocks immediately 
following removal of drug application unless otherwise noted. When comparing 
antagonist effects on the norepinephrine-induced increase in sEPSCs, a repeated 
measures one-way ANOVA was used, followed by a Tukey’s post-test to determine the 
significance of specific comparisons. Degrees of freedom were corrected using 
Greenhouse-Geisser estimates of sphericity. For the electrophysiology studies, “n” 
refers to the number of cells. At least four animals were used in each electrophysiology 
experiment. All values given throughout the study are presented as mean ± S.E.M. 
 
Pharmacology 
 Isoproterenol hydrochloride, tetrodotoxin citrate, and picrotoxin were purchased 
from Tocris Bioscience. Norepinephrine bitartrate salt monohydrate, methoxamine 
hydrochloride, and prazosin hydrochloride were purchased from Sigma-Aldrich. All 
experimental drugs were bath applied at their final concentrations as noted in the text. 
Dimethylsulfoxide (DMSO) was the solvent used for stock solution of picrotoxin where 
the maximum final concentration of DMSO in ACSF was 0.02% by volume. All other 
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drugs, with the exception of prazosin, were easily dissolved in water. Prazosin was 
dissolved in water with vigorous heating and stirring. 
 
Results 
  
Electrophysiological characteristics of RLi dopamine neurons 
 We first wanted to confirm that the TH-eGFP mouse line would adequately report 
dopamine neurons in the RLi. To examine this, sections were processed for 
immunostaining for anti-TH and the numbers of eGFP+, TH+, and double labeled 
neurons were counted in images captured from each section with a 20x lens. In the RLi, 
the percentage of eGFP+ cells that were co-localized with TH+ cells was 95 ± 1% (n = 
3) (Figure 7B-E). These data suggest that eGFP fluorescence in this mouse line is a 
good marker for dopamine neurons located in the RLi. 
 It has been reported that dopamine neurons have distinct electrophysiological 
profiles based on their projection targets and anatomical location (Lammel et al., 2011; 
Margolis et al., 2008). Therefore, we examined the basic electrophysiological properties 
of eGFP positive neurons located in the RLi and lateral VTA, specifically the 
parabrachial pigmented nucleus. Using whole-cell voltage clamp, we measured 
membrane resistance, membrane capacitance, and hyperpolarization-activated (Ih) 
current of TH-eGFP neurons in the RLi and VTA.  RLi eGFP+ neurons exhibited a 
significantly higher membrane resistance (745 ± 115 MΩ, n = 16) than eGFP+ neurons 
in the lateral VTA (195 ± 53 MΩ, n = 10, p < 0.01) (Figure 7F). Further, the RLi neurons 
also displayed a smaller membrane capacitance (25 ± 2 pF, n = 16) than eGFP+ 
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neurons in the lateral VTA (56 ± 5 pF, n = 10, p < 0.0001) (Figure 7G). Having 
established these differences in basic membrane properties, we next sought to 
determine if the eGFP+ neurons in the RLi exhibit an Ih current. The presence of Ih 
current has long been used as a marker for dopamine neurons in the VTA (Grace and 
Onn, 1989; Hopf et al., 2007; Lacey et al., 1989; Margolis et al., 2006; Stuber et al., 
2008). Recently, it has been shown that a subset of dopamine neurons do not possess 
a robust Ih current (Lammel et al., 2011; Margolis et al., 2006; Margolis et al., 2008). 
Consistent with this, we found that lateral VTA eGFP+ neurons displayed an Ih current 
similar to those observed in previous studies (-173 ± 46 pA, n = 10 cells from 4 mice) 
(Ungless et al., 2003). However, the eGFP+ neurons in the RLi of the same mice had a 
significantly smaller Ih current (-14 ± 4 pA, p < 0.001, n = 16 cells from 4 mice) when 
compared to the lateral VTA (Figure 7H-J), with most neurons lacking any measurable 
current.  
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Figure 7:  RLi dopamine neurons have distinct basal excitability profiles.   
(A) Diagram of a coronal brain section image from Franklin & Paxinos mouse 
atlas showing region selected for VTA electrophysiology recordings.  (B) Diagram 
of a coronal brain section image from Franklin & Paxinos mouse atlas showing 
region selected for RLi electrophysiology recordings.  (C) Coronal section of the 
RLi corresponding to the black rectangle in B displaying eGFP fluorescence, (D) 
tyrosine hydroxylase immunohistochemistry, and (E) the merged image showing 
the co-localization of eGFP and tyrosine hydroxylase labeled neurons. The 
arrows highlight examples of double labeled cells.  (F) Bar graph showing the 
membrane resistance of eGFP positive neurons in the RLi and VTA. The eGFP 
positive neurons in the RLi exhibited a significantly higher membrane resistance 
compared to those in the VTA (** denotes p < 0.01). (G) Bar graph showing the 
capacitance of eGFP positive neurons in the RLi and VTA. The eGFP positive 
neurons in the RLi exhibited a significantly reduced capacitance compared to 
those in the VTA (**** denotes p < 0.0001).  (H) Bar graph comparing the average 
peak Ih current for each group of dopamine neurons. There was a significant 
difference in the Ih current in the VTA dopamine neurons compared to dopamine 
neurons in the RLi (*** denotes p < 0.001).  (I) A hyperpolarization voltage step in 
an eGFP positive neuron in the VTA leads to a robust inward current.  (J) A 
hyperpolarization voltage step in an eGFP positive neuron in the RLi leads to a 
small but measureable inward current. 
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Norepinephrine enhances spontaneous excitatory transmission on TH-eGFP positive 
neurons in the RLi via activation of α1 adrenergic receptors 
 
The RLi projects to regions heavily involved in stress responding and receives a 
large noradrenergic projection (Mejias-Aponte et al., 2009). Thus, we tested the 
hypothesis that norepinephrine modulates RLi dopamine neurons. We first examined 
the effects of norepinephrine on basal excitability and found no effect on holding current 
(107 ± 8% of baseline, p > 0.05, n = 8) or membrane resistance (106 ± 6% of baseline, 
p > 0.05, n = 8). Because norepinephrine has been shown to regulate excitatory drive in 
other brain regions, we measured sEPSCs on TH-eGFP neurons located in the RLi 
(average basal frequency, 2.4 ± 0.3 Hz; average basal amplitude, 20 ± 1 pA, n = 28) 
(Figure 8A). We bath applied norepinephrine (50 µM) for 10 minutes while spontaneous 
glutamatergic transmission was monitored using whole cell patch-clamp recordings in 
acutely prepared brain slices. We found that this norepinephrine application resulted in 
an increase in the frequency of sEPSCs (473 ± 93% of basal frequency, F (1.3, 9.2) = 
13.9, p < 0.01, n = 8) (Figure 8B). Additionally, there was a modest, but significant effect 
on sEPSC amplitude (128 ± 11% of basal amplitude, F (14, 98) = 2.2, p < 0.05, n = 8) 
(Figure 8C). This increase in amplitude was present only during the last 5 minutes of 
norepinephrine application. There was no effect of norepinephrine on sEPSC rise time 
(93 ± 7% of baseline, p > 0.05, n = 8) or decay time (97 ± 4% of baseline, p > 0.05, n = 
8). 
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Figure 8: Norepinephrine increases spontaneous glutamatergic 
transmission onto RLi dopamine neurons.   
(A) Representative sEPSC recordings in the RLi demonstrating the ability of 
norepinephrine (NE) to enhance glutamatergic transmission.  (B) A 10 min 
application of 50 µM norepinephrine increases sEPSC frequency onto RLi 
dopamine neurons. (C)  A 10 min application of 50 µM norepinephrine modestly 
increases sEPSC amplitude onto RLi dopamine neurons only during the last 5 
minutes of drug application. 
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 Since norepinephrine can act on multiple adrenergic receptors (ARs), we next 
tested whether α1-, α2-, and/or β-ARs were responsible for the actions of norepinephrine 
on glutamatergic transmission in RLi TH-eGFP neurons. We found that application of 
the α1-AR agonist methoxamine (100 µM) increased sEPSC frequency (581 ± 169% of 
basal frequency, F (1.3, 10) = 9.1, p < 0.01, n = 9) (Figure 9A) but not amplitude (117 ± 
10% of basal amplitude, F (1.5, 12) = 2.0, p = 0.18, n = 9) (Figure 9B) in TH-eGFP 
positive neurons in the RLi. Preapplication of the α1-AR antagonist prazosin (10 µM) 
prevented norepinephrine induced increases in sEPSC frequency and amplitude. In 
fact, application of norepinephrine in the presence of prazosin led to a decrease in 
sEPSC frequency (60 ± 6% of basal frequency, F (2.8, 11) = 13, p < 0.001, n = 5) and a 
modest decrease in sEPSC amplitude (91 ± 2% of basal amplitude, F (17, 68) = 2.4, p < 
0.01, n = 5) (Figure 9C,D). To further investigate these decreases in sEPSC frequency 
and amplitude, we applied the α2-AR agonist UK-14,304. A 10 minute application of UK-
14,304 (1 µM) led to a significant decrease in sEPSC frequency (60 ± 9% of basal 
frequency,	  F (2.5, 12) = 6.8, p < 0.01, n = 6) with a trend toward a decrease in sEPSC 
amplitude (89 ± 5% of basal amplitude,	  F (2.3, 12) = 3.0, p = 0.08, n = 6) (Figure 
10A,B). Since activation of β-ARs can lead to increases in sEPSC frequency in other 
brain regions such as the BNST, we applied the β-AR agonist isoproterenol (3 µM) for 
10 minutes and found that this application of isoproterenol did not lead to changes in 
sEPSC frequency (104 ± 16% of basal frequency,	  F (2.4, 17) = 0.35, p > 0.05, n = 8) or 
amplitude (96 ± 5% of basal amplitude, F (1.9, 13) = 1.2, p > 0.05, n = 8) (Figure 
10C,D). These data indicate that norepinephrine enhances the spontaneous 
glutamatergic transmission in RLi TH-eGFP neurons via activation of α1-ARs. 
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Figure 9: Activation of α1-ARs increases sEPSC frequency onto RLi 
dopamine neurons.  
(A) A 20 min application of 100 µM methoxamine (methox) increases sEPSC 
frequency onto RLi dopamine neurons.  (B) A 20 min application of 100 µM 
methoxamine has no effect on sEPSC amplitude onto RLi dopamine neurons.  (C) 
In the presence of the α1-AR antagonist prazosin (10 µM), a 10 min application of 
50 µM norepinephrine decreases the frequency of sEPSCs onto RLi dopamine 
neurons.  (D) In the presence of the α1-AR antagonist prazosin (10 µM), a 10 min 
application of 50 µM norepinephrine modestly decreases the amplitude of sEPSCs 
onto RLi dopamine neurons. 
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Figure 10:  α2-AR activation depresses glutamatergic transmission and  
β-AR activation has no effect on glutamatergic transmission onto RLi 
dopamine neurons.   
(A) A 10 min application of 1 µM UK-14,304 decreases sEPSC frequency onto 
RLi dopamine neurons.  (B) A 10 min application of 1 µM UK-14,304 causes a 
trend toward a decrease in sEPSC amplitude onto RLi dopamine neurons.  (C) 
A 10 min application of 3 µM isoproterenol (Iso) has no effect on sEPSC 
frequency or (D) sEPSC amplitude onto RLi dopamine neurons. 
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Noradrenergic enhancement of excitatory transmission on TH-eGFP positive RLi 
neurons is transient 
 
To further investigate the time course of norepinephrine’s enhancement of 
excitatory transmission in RLi TH-eGFP neurons, we bath applied prazosin (10 µM) to 
slices 10 minutes after a 10 minute application of norepinephrine was completed. The 
prazosin was able to reverse the increase in frequency of sEPSCs caused by 
norepinephrine (Figure 11A,C) (F(1.0, 5.2) = 8.9, p < 0.05, n = 6). It also reduced the 
modest increase in amplitude of sEPSCs caused by norepinephrine (Figure 11B,D) 
(F(1.6, 8.1) = 13, p < 0.01, n = 6). These results indicate that the increase in 
glutamatergic transmission in RLi TH-eGFP neurons is not due to long term potentiation 
of excitatory inputs but rather from transient effects of α1-AR activation.   
 
α1-AR activation increases excitatory transmission in an activity-independent manner  
 
To further investigate the mechanism of action of norepinephrine’s effects on RLi 
TH-eGFP neurons, we examined the ability of methoxamine to modulate activity-
independent miniature EPSCs (mEPSCs). mEPSCs were isolated by the addition of the 
sodium channel blocker TTX (1µM) to the bath solution (average basal frequency, 1.8 ± 
0.8 Hz; average basal amplitude 15 ± 1 pA, n = 7). We found that methoxamine 
enhanced mEPSC frequency (535 ± 128% of basal frequency, p < 0.05, n = 7) (Figure 
12A-C), but had no effect on mEPSC amplitude (112 ± 6% of basal amplitude, n = 7) 
(Figure 12D) in RLi TH-eGFP neurons. These results indicate that the α1-AR induced 
enhancement of glutamatergic transmission in RLi TH-eGFP neurons occurs via an 
activity-independent mechanism and provide evidence that norepinephrine’s site of 
action on RLi TH-eGFP neurons is presynaptic. 
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Figure 11:  Norepinephrine’s actions on sEPSCs are transient.   
(A,C) The norepinephrine induced increase in sEPSC frequency does not persist 
when followed by a 15 min application of 10 µM prazosin (* denotes p < 0.05).  
(B,D) The norepinephrine induced increase in sEPSC amplitude does not persist 
when followed by a 15 min application of 10 µM prazosin (** denotes p < 0.01). 
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Figure 12:  Methoxamine increases mEPSC frequency but not amplitude.   
(A) Representative mEPSC recordings in the RLi demonstrating the ability of 
methoxamine to enhance glutamatergic transmission.  (B) A representative 
experiment showing the effect of 100 µM methoxamine on mEPSC frequency 
onto RLi dopamine neurons.  (C) A 20 min application of 100 µM methoxamine 
increases mEPSC frequency onto RLi dopamine neurons (* denotes p < 0.05).  
(D) A 20 min application of 100 µM methoxamine has no effect on mEPSC 
amplitude onto RLi dopamine neurons.   
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Discussion 
Because of the small size of the RLi coupled with the lack of Ih in RLi dopamine 
neurons, a reporter method is necessary to identify these neurons for 
electrophysiological analysis. Thus we analyzed the properties of these neurons in a 
TH-eGFP line previously utilized for analysis of dopamine neurons (Li et al., 2013a). In 
an initial characterization of the basic membrane properties of eGFP positive neurons in 
the RLi of these transgenic mice, we found several significant differences as compared 
to eGFP positive lateral parabrachial pigmented nucleus VTA neurons. The dopamine 
neurons in the RLi had a significantly greater membrane resistance when compared to 
the dopamine neurons in the parabracial pigmented nucleus of the VTA. Additionally, 
we found that the capacitance was significantly smaller in the RLi neurons. Finally, we 
found little to no Ih current in the RLi dopamine neurons.  Other groups have also found 
a lack of Ih current in dopamine neurons with anatomical locations near the midline 
(Lammel et al., 2011; Li et al., 2013a). Functionally, these properties are expected to 
affect differences in excitability and may influence plasticity of synaptic transmission. 
Our findings suggest fundamental differences in the basic membrane and excitability 
properties between the afferent dopaminergic projections to the BNST from the VTA 
and RLi. These findings raise the possibility that these neurons may exhibit different 
firing patterns in vivo and thus be regulated differently by exposure to stressors or drugs 
of abuse. 
Norepinephrine acts as a powerful modulator of excitatory neurotransmission in 
many brain areas. We found that the most pronounced effect of norepinephrine on RLi 
dopamine neuron physiology was an increase in the frequency of sEPSCs. Since 
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activation of β-ARs increases excitatory transmission in the hippocampus, CeA, and 
BNST, we attempted to mimic the effects of norepinephrine with the β-AR agonist 
isoproterenol (Egli et al., 2005; Gereau and Conn, 1994; Nobis et al., 2011). However, 
isoproterenol had no effect on sEPSC frequency or amplitude.  
In the BNST, activation of α1-ARs elicits long term depression of evoked 
glutamatergic transmission, but an increase in sEPSCs. Similarly, activation of α1-ARs 
leads to an enhancement of glutamatergic transmission onto VTA dopamine neurons 
(McElligott and Winder, 2008; McElligott et al., 2010; Velasquez-Martinez et al., 2012). 
In the presence of the α1-AR antagonist prazosin, we found that norepinephrine did not 
increase excitatory transmission. In fact, when α1-ARs were blocked, norepinephrine 
decreased sEPSC frequency and amplitude.  Since the α2-AR agonist UK-14,304 led to 
a depression of sEPSC frequency and a trend toward a decrease in sEPSC amplitude, 
this decrease in excitatory transmission is likely due to the activation of α2-ARs. 
Similarly, activation of α2-ARs decreases excitatory transmission in the BNST and onto 
VTA dopamine neurons (Egli et al., 2005; Jimenez-Rivera et al., 2012; Shields et al., 
2009). It is possible that this decrease in glutamatergic transmission is also due to the 
blockade of tonically active α1-ARs (Grenhoff and Svensson, 1993). However, the timing 
of the effect coincides with norepinephrine application which supports α2-AR activation 
mediating this decrease in excitatory transmission. It is important to note that the overall 
effect of norepinephrine on RLi dopamine neurons is an increase in excitatory 
transmission and the small α2-AR mediated decrease in sEPSC frequency is surpassed 
by the large α1-AR mediated increase in sEPSC frequency. 
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Since the effect of norepinephrine on sEPSC frequency was blocked by the α1-
AR antagonist, we attempted to mimic it with the α1-AR agonist methoxamine. Indeed, 
methoxamine mimicked the effects of norepinephrine on RLi sEPSC frequency. This 
finding is a similar to that seen in VTA dopamine neurons (Velasquez-Martinez et al., 
2012). In the RLi, the frequency of mEPSCs increases with the activation of α1-ARs. 
The increase in mEPSC frequency indicates that α1-ARs may act presynaptically to 
increase excitatory transmission on RLi dopamine neurons and that their actions are 
independent of presynaptic action potentials.  While activation of α1-ARs in VTA 
dopamine cells does not modulate mEPSCs, activation of α1-ARs in other brain regions, 
such as the hypothalamus, does lead to an increase in mEPSC frequency (Gordon and 
Bains, 2003). The VTA dopamine neurons were identified via a large Ih current ( > 200 
pA) and are located more laterally, while the RLi dopamine neurons have very small, 
almost negligible, Ih current and are located along the midline. Therefore, these are 
entirely different populations of dopamine neurons which may differ in their response to 
inputs and outputs to projection targets. Both the lateral VTA and the RLi receive 
noradrenergic inputs from the locus coeruleus (LC) and the norepinephrine brainstem 
centers, A1, A2 and A5 (Mejias-Aponte et al., 2009). However, the lateral VTA has a 
higher percentage of its norepinephrine input arising from the LC, while the RLi has a 
higher percentage of its norepinephrine input arising from the brainstem centers. This 
might lead to differences in how these two groups of dopamine neurons respond to 
stimuli, such as stress, that lead to the release of norepinephrine in target regions. 
This study indicates a potential mechanism through which norepinephrine could 
recruit the activity of RLi dopamine neurons. Since activation of glutamatergic afferents 
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mediates the firing of dopamine neurons, we would expect this α1-AR mediated 
enhancement in excitatory transmission to increase the firing of dopamine neurons and 
release of dopamine in target regions. Stressors have been shown to increase 
dopamine concentration in many target regions (Abercrombie et al., 1989; Deutch et al., 
1991; Kalivas and Duffy, 1995; Morrow et al., 2000; Sutoo and Akiyama, 2002).  Stress 
causes norepinephrine release, which our data suggests would lead to an increase in 
excitatory drive on RLi dopamine neurons via α1-AR activation. One possibility is that 
this drives dopamine release in target regions such as the BNST, where it may 
participate in reinforcement related behaviors as well as anxiety responses. Thus 
norepinephrine induced enhancement of excitatory drive on RLi dopamine neurons is a 
potential mechanism through which RLi dopamine neurons may be involved in the 
stress response. 
 
 
 
 
 
 
 
 
 
 
 
Adapted with permission from: 
Williams MA, Li C, Kash TL, Matthews RT, Winder DG. 2014. Excitatory drive onto 
dopaminergic neurons in the rostral linear nucleus is enhanced by norepinephrine in an 
alpha1 adrenergic receptor-dependent manner. Neuropharmacology 86:116-24 
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CHAPTER IV 
 
Discussion and Future Directions 
 
In this dissertation, I have described my studies on noradrenergic modulation of 
RLi DA neurons, an understudied group of DA cells.  I found that NE leads to an α1-AR 
mediated increase in excitatory transmission that appears to have a presynaptic site of 
action. There was also an α2-AR mediated decrease in excitatory transmission, but the 
overall effect of NE was an increase in excitatory transmission. The overall effect of NE 
on excitatory transmission varies by brain region. For example, in the BNST the overall 
effect of NE due to the activation of α1- and α2-ARs is a decrease in excitatory 
transmission. Activation of α1-ARs in the BNST leads to LTD, while the activation of α2-
ARs leads to an input specific, transient depression of excitatory transmission (Egli et 
al., 2005; Flavin et al., 2014; McElligott and Winder, 2008; McElligott et al., 2010; 
Shields et al., 2009). These varying effects of NE could be due to a variety of factors 
including differential in vivo recruitment of NE inputs, differential regulation of glutamate 
inputs, length of agonist application, specific subtypes of ARs involved, and synaptic 
site of action of the receptor.  
An interesting characteristic of RLi DA neurons is that they lack Ih and have a 
higher membrane resistance than lateral VTA DA neurons (Williams et al., 2014). These 
postsynaptic characteristics are likely to lead to less filtering of synaptic inputs (Magee, 
2000). Therefore, even though both VTA and RLi DA neurons undergo modulation of 
excitatory transmission by NE, RLi DA neurons may be more likely to undergo changes 
in firing due to NE modulation of excitatory transmission. In addition, midline DA 
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neurons may have a lower expression of DAT and D2Rs so they are likely to have a 
sustained pattern of DA release compared to lateral VTA DA neurons (Lammel et al., 
2008). Therefore, endogenous release of NE into the VTA and RLi may have differing 
effects on downstream target regions with the potential for larger changes in RLi DA 
release. 
 
RLi dopamine neurons may respond to aversive stimuli 
As discussed in Chapter I, the majority of DA neurons respond to rewarding 
stimuli, however, there is a small subset of DA neurons that respond to aversive stimuli. 
In fact, activation of the lateral habenula input to medial VTA DA neurons that project to 
PFC causes conditioned place aversion (CPA) behavior in animals (Lammel et al., 
2012). The DA neurons that respond to aversive stimuli are located in the medial 
aspects of the VTA, lack Ih, and primarily project to the PFC (Brischoux et al., 2009; 
Lammel et al., 2011; Lammel et al., 2012). RLi DA neurons also lack Ih and project to 
the PFC (Deutch et al., 1991; Williams et al., 2014). In addition, RLi DA neurons receive 
NE input from a variety of NE cell groups and project to areas of the extended 
amygdala, such as the CeA and BNST, that play roles in anxiety related behaviors 
(Hasue and Shammah-Lagnado, 2002; Mejias-Aponte et al., 2009). Based on these 
similarities and the circuitry of RLi DA neurons, it seems likely that the RLi DA neurons 
respond to aversive stimuli. DA’s involvement in motivated behavior is often thought to 
underlie hedonic responses, appetitive motivation and reinforcement based learning. 
However, DA signaling is important in aversive aspects of learning and motivation as 
well, such as the need to escape a harmful or stressful environment (Salamone and 
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Correa, 2012). This might be one reason why a subset of DA neurons respond to 
aversive rather than rewarding stimuli. 
 
Norepinephrine may recruit RLi dopamine neurons during a variety of behaviors 
The α1-AR mediated increase in excitatory transmission onto RLi DA neurons 
may recruit this population of DA neurons during times of stress. The NE input to the 
RLi comes from the LC, A1, A2, and A5 areas (Mejias-Aponte et al., 2009). 
Endogenous NE from any one of these individual NE sources or NE from a variety of 
sources may underlie the α1-AR mediated increase in excitatory transmission onto RLi 
DA neurons. Stressors such as restraint and foot shock, as well as physiological 
stressors such as cardiovascular, osmotic, and immune challenges activate cells in the 
LC, A1 and A2 (Abercrombie and Jacobs, 1987; Morilak et al., 1987; Sawchenko et al., 
2000). In Chapter I, I also discussed a variety of evidence indicating that DA neurons 
are recruited during stress, including changes in DA metabolism and release and 
alterations in the firing of DA neurons following a stressor. Therefore, one hypothesis is 
that NE released from the LC, A1 and/or A2 during stress acts on α1-ARs in the RLi to 
increase excitatory transmission onto RLi DA neurons and recruit them (Figure 13).  
This increase in excitatory transmission would presumably lead to increases in the firing 
of RLi DA neurons and increase DA in downstream regions such as the PFC and 
BNST. The BNST plays important roles in stress and anxiety responses, as well as 
stress-induced reinstatement of drug-seeking (Briand et al., 2010; Davis et al., 2010; 
Erb, 2010; Koob, 2009). In addition, DA inhibits the firing of LC neurons via activation of 
α2-ARs (El Mansari et al., 2010), and in contrast, stimulation of the VTA dopaminergic 
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projection to the LC results in activation of the LC (Deutch et al., 1986), so the increase 
in DA following stress could then feedback to modulate further LC activity. It is possible 
that the recruitment of RLi DA neurons by NE during stress or the dysregulation of this 
system may contribute to stress-induced reinstatement of drug-seeking or the 
development of anxiety disorders. 
Some of the NE areas that innervate the RLi are involved in homeostatic 
regulation. For example, A1 neurons control the release of vasopressin, A2 neurons are 
involved in regulation of food intake, and A5 neurons regulate the respiratory rhythm 
generator of the rostral ventrolateral medulla (Blessing and Willoughby, 1985; Hilaire et 
al., 2004; Rinaman, 2003). During disturbances in these homeostatic processes, it may 
be possible that NE acts through α1-ARs to recruit RLi DA neurons.  The RLi DA 
neurons may underlie the motivational drive required to initiate a behavioral action that 
will help restore homeostasis.  
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Figure 13: Model depicting the potential actions of stress on RLi circuitry. 
Stress initiates a release of NE from the LC or A1 and A2 regions. NE increases 
excitatory transmission onto RLi DA neurons which likely increases DA in target 
regions of the RLi such as the dBNST or PFC. In the dBNST, increased 
extracellular dopamine leads to increased excitatory transmission and could 
initiate stress-induced reinstatement of drug-seeking behavior. In the PFC, high 
increases in DA lead to impaired working memory. (Briand et al., 2010; Kash et 
al., 2008; Williams et al., 2014) 
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NE from the LC is involved in attention related behaviors. Tonic LC firing favors 
exploration of new or changing environments while phasic LC mode is associated with 
focused attention (Clayton et al., 2004). DA has been called a “teaching” signal in 
reinforcement learning that predicts when rewards are likely to occur (Montague et al., 
1996; Montague et al., 2004). These ideas led to a theory for NE-DA interactions during 
learning and motivated behaviors developed by Aston-Jones and Cohen. LC tonic firing 
encourages exploration and when a new reward is discovered the DA teaching signal 
strengthens the behaviors that led to the reward. Then the LC goes into phasic mode to 
focus attention on the new reward, and when the reward is gone or no longer needed 
the LC switches back into tonic mode to encourage exploration (Aston-Jones and 
Cohen, 2005). It is possible that LC NE and RLi DA interact in this way. Alternatively, 
LC NE and VTA DA might coordinate during reinforcement learning associated with 
rewards, while LC NE and RLi DA might underlie reinforcement learning that occurs due 
to exposure to aversive stimuli. 
The NE modulation of RLi DA neurons could play a role in many behaviors. 
There is still much work to be done to understand the importance of the actions of RLi 
DA neurons. An important area of future research is to determine what behaviors RLi 
DA neurons mediate and, more specifically, to determine the role of the α1-AR mediated 
facilitation of excitatory transmission onto RLi DA neurons in behavior.  
 
α1-AR mediated enhancement of excitatory transmission onto vPAG dopamine 
neurons may promote wakefulness 
 
In addition to the actions of α1-AR on RLi DA neurons, I found that the activation 
of α1-ARs enhances excitatory transmission onto vPAG DA neurons as well (Figure 21 
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in Appendix C). The vPAG DA neurons have been shown to promote wakefulness (Lu 
et al., 2006). Interestingly, prazosin, the α1-AR antagonist, has proven efficacious in 
treating nightmares and sleep disturbances in people with PTSD (Mohsenin and 
Mohsenin, 2014; Raskind et al., 2007; Taylor et al., 2008). It is possible that prazosin is 
acting at α1-ARs in the vPAG to dampen excitatory transmission onto the vPAG wake 
promoting DA neurons, which would induce sleep. Modafinil is a medication that is used 
to treat excessive sleepiness that arises from narcolepsy and other sleep disorders. The 
mechanism of action of modafinil in promoting wakefulness has yet to be elucidated. 
Using DBH knockout mice, which lack NE and have hypersensitive DA signaling, the 
Weinshenker lab determined that modafinil’s effects in promoting wakefulness involve 
both NE and DA, as well as the activation of α1-ARs (Mitchell et al., 2008). This led to 
the hypothesis that modafinil acts to block NET in the vPAG which will increase NE and 
lead to an enhancement of excitatory transmission onto vPAG DA neurons through the 
activation of α1-ARs (Mitchell et al., 2008). In addition, modafinil may act to block DAT 
which will lead to increased DA in projection regions of the vPAG DA neurons. 
Simultaneously, modafinil’s blockade of NET will lead to NE induced inhibition of sleep-
promoting neurons in the hypothalamus. The work I have shown in this dissertation 
regarding α1-AR mediated increases in excitatory transmission onto vPAG DA neurons 
supports this mechanism of action for modafinil.  
 
Activation of RLi dopamine neurons may have behavioral consequences 
 One of the most important questions underlying the study of RLi DA neurons is 
the question of behavioral relevance. If RLi DA neurons appear to act similarly to 
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classically studied VTA DA neurons, then their further characterization may be 
unnecessary. Therefore, it is necessary to identify behavioral actions of RLi DA 
neurons. It seems likely that RLi DA neurons are part of the unique subset of DA 
neurons that respond to aversive stimuli or that RLi DA neurons contribute to anxiety 
related behaviors. The future directions outlined in this section investigate the role of 
RLi DA neurons in behavior. 
 
The activation of RLi dopamine neurons may lead to anxiety like behavior 
 Evidence indicates that RLi DA neurons are recruited during stress, and I have 
shown that activation of α1-ARs causes an increase in excitatory transmission that 
would likely lead to an increase in firing of RLi DA neurons (Deutch et al., 1991; 
Williams et al., 2014). In addition, prazosin can reduce the severity of PTSD symptoms 
(Green, 2014). In terms of treating PTSD, prazosin could have many sites of action, but 
it is possible that it is acting at dampening excitatory transmission onto RLi DA neurons. 
To look at the role of RLi DA neurons in stress related responses such as anxiety, in 
vivo optogenetics could be used. To specifically target RLi DA neurons, a DIO 
channelrhodopsin (ChR2) virus could be injected into the RLi of TH-cre mice and an 
optrode implanted into the RLi. Activation of ChR2 by the blue light activates the RLi DA 
neurons similarly to the α1-AR mediated increase in glutamatergic transmission. Basic 
anxiety tests such as EPM or open field could be used to test for anxiety. If activation of 
the RLi DA neurons induces anxiety, activation of ChR2 may lead to less time spent in 
the open arms of EPM and less center time in open field. Another behavior test that the 
lab uses to measure stress induced anxiety is novelty induced hypophagia (NIH). In this 
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test, animals are trained to consume a palatable substance such as a vanilla shake. In 
the home cage, a familiar environment, the mouse quickly approaches the vanilla 
shake, but in a novel cage, there is a conflict between the desire of the vanilla shake 
and the novel environment. If the RLi DA neurons play a role in anxiety, activation of 
ChR2 in the RLi during testing days may increase the latency to eat the palatable 
substance in the novel cage. If the results of these experiments do indicate that RLi DA 
neurons play a role in anxiety behavior, halorhodopsin could be used to inhibit RLi DA 
neurons. The prediction is that inhibition of these cells causes a decrease in anxiety 
related behaviors. Appendix B describes preliminary efforts utilizing optogenetics to 
investigate the actions of RLi DA neurons. 
 
RLi dopamine neurons may play a role in stress-induced reinstatement of drug-seeking 
behavior 
 
 The RLi DA neurons project to the BNST, a region critical for stress-induced 
reinstatement of drug-seeking behavior (Briand et al., 2010). In particular, NE signaling 
in the BNST, particularly through α1- and β-ARs, initiates stress-induced reinstatement 
(Leri et al., 2002; Mantsch et al., 2010; Vranjkovic et al., 2014). In addition, a systemic 
injection of prazosin, the α1-AR antagonist, blocks stress induced reinstatement of 
alcohol seeking (Le et al., 2011). In this study, prazosin may act within the BNST, but it 
may also have converging actions elsewhere, such as the RLi.  One hypothesis is that 
RLi DA neurons may act to recruit the BNST during stress-induced reinstatement. 
Stress engages NE centers which may lead to α1-AR mediated increases in excitatory 
transmission onto RLi DA neurons and presumably an increase in DA release in 
downstream regions.  In the BNST, DA has been shown to have many actions which 
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include increases in sEPSCs and decreases in inhibitory transmission (Kash et al., 
2008; Krawczyk et al., 2011a). Therefore, an increase in RLi DA release in the BNST is 
likely to lead to an increase in BNST activity which may lead to drug-seeking behavior. 
The role RLi DA neurons play in reinstatement of drug-seeking behavior can be tested 
through the use of in vivo optogenetics. A DIO ChR2 virus could be injected into the RLi 
of TH-cre mice and an optrode implanted in the RLi. If RLi DA neurons mediate stress-
induced reinstatement, activation of RLi DA neurons may initiate reinstatement of 
cocaine conditioned place preference (CPP) following extinction, a behavioral paradigm 
that the lab has experience with (Conrad et al., 2013). If there is no effect on stress-
induced reinstatement of cocaine CPP, stress-induced reinstatement of alcohol self-
administration could be investigated, since prazosin has been shown to block this 
behavior in rats and other midline DA neuron groups are involved in the reinforcing 
effects of alcohol (Le et al., 2011; Li et al., 2013a). Interestingly, prazosin has also 
demonstrated effectiveness in reducing drinking in clinical trials of alcohol dependence 
(Muller et al., 2014; Simpson et al., 2009). 
In addition, the actions of ablation of RLi DA neurons on stress-induced 
reinstatement could be investigated using a diphtheria toxin ablation strategy. In this 
method, an AAV-FLEX-DTR virus is injected into the RLi of TH-cre mice which 
incorporates the human diphtheria toxin receptor into RLi DA neurons.  Then i.p. 
injections are used to systemically deliver diphtheria toxin which only kills cells that 
express the receptor, i.e. the RLi DA neurons. If the hypothesis is correct, ablation of 
RLi DA neurons blocks stress-induced reinstatement of cocaine CPP. It is possible that 
ablation of RLi DA neurons may interfere with the establishment of CPP.  If this is the 
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case, the diphtheria toxin injections could be done after CPP has been established. 
These experiments indicate whether the RLi DA neurons are essential for stress-
induced reinstatement. 
 
The activation of RLi dopamine neurons may impair working memory 
The RLi DA neurons that are activated by stress project to the PFC (Deutch et 
al., 1991). The PFC is known to mediate working memory through persistent firing of 
cortical pyramidal neurons (Goldman-Rakic, 1995). Stress impairs working memory 
through high levels of D1 receptor activation that reduce PFC neuronal firing 
(Vijayraghavan et al., 2007). Recently it was determined that stress induced D1 receptor 
mediated increases in cAMP lead to the opening of hyperpolarization-activated cyclic 
nucleotide-gated (HCN) channels which increases Ih and inhibits cell firing (Gamo et al., 
2015). DA is known to have an inverted U-shaped effect in the PFC where moderate 
levels of DA are beneficial but high levels of DA are detrimental and impair PFC function 
(Vijayraghavan et al., 2007). Therefore, in times of stress DA increases in the PFC may 
lead to impaired working memory. This stress induced DA release may be from RLi DA 
neurons. One hypothesis is that activation of RLi DA neurons may impair PFC mediated 
working memory. To test this hypothesis, in vivo optogenetics studies such as those 
outlined above could be used in combination with a delayed alternation spatial working 
memory task in a T-maze. Activation of RLi DA neurons may impair working memory in 
this task. Patients with schizophrenia have an upregulation of D1 receptor expression in 
the PFC and show impaired working memory that is exacerbated with stress (Abi-
Dargham et al., 2012). Investigations into the actions of RLi DA neurons and working 
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memory may lead to novel treatment mechanisms for schizophrenia and other 
psychiatric disorders. 
RLi DA neurons project to both the BNST and the PFC, brain regions involved in 
stress, anxiety and reward related behaviors. One interesting question is the issue of 
collateralization and whether the same RLi DA neuron projects to both of these brain 
regions. There is evidence for collateralization of some groups of DA neurons, while 
others don’t show much collateralization. For example, some nigrostriatal DA neurons 
send collaterals to the thalamus (Freeman et al., 2001), while there is minimal collateral 
branching of VTA DA projections to the primary motor cortex, NAc and PFC (Hosp et 
al., 2015). Whether or not the RLi DA projections to the PFC and BNST arise from the 
same neurons or different subsets of RLi DA neurons, stress may increase DA in both 
of these regions. The PFC sends glutamatergic projections to the BNST (Massi et al., 
2008). This triad sets up an interesting circuit that could play important roles in many 
stress related behaviors and pathologies (Figure 14). 
 
RLi dopamine neurons may mediate conditioned place aversion behavior 
As discussed above RLi DA neurons share characteristics with the subset of DA 
neurons that respond to aversive stimuli. Therefore, it might be possible that activation 
of RLi DA neurons mediates conditioned place aversion behavior. This hypothesis can 
be tested using in vivo optogenetics in a TH-cre mouse line as outlined above. During 
the conditioning session, ChR2 is activated on one side of a two chamber apparatus. If 
activation of RLi DA neurons induces CPA, on the testing day the mouse may prefer the 
chamber where it did not experience the light activation.  
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If the RLi plays a role in any of the above behaviors, further characterization of 
RLi DA neurons might reveal mechanisms that could contribute to the development of 
novel treatments for schizophrenia, anxiety disorders or addiction. Recruitment of RLi 
DA neurons during these behaviors may be due to increases in excitatory drive. Since 
my studies indicate that activation of α1- and α2-ARs modulate excitatory transmission 
onto RLi DA neurons, further characterization and manipulation of these systems could 
uncover treatments for these pathological conditions. 
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Figure 14: Model depicting the circuit triad of the RLi, PFC and BNST. 
The RLi DA neurons project to both the BNST and the PFC. It is possible that the 
same DA neurons project to both of these regions or that subsets project to each 
region. Stress may increase RLi DA in the BNST and PFC. The PFC sends 
glutamatergic afferents to the BNST. This triad could play important roles in 
many behaviors such as working memory and stress-induced reinstatement of 
drug-seeking. 
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Stress may increase glutamatergic transmission onto RLi dopamine neurons in 
an α1-AR dependent manner 
 
An important question to address is to determine the role of the α1-AR mediated 
facilitation of excitatory transmission onto RLi DA neurons in behavior. The literature 
indicates that after administration of an acute stressor DA concentration and 
metabolism increase in DA projection regions such as the NAc, mPFC, and CeA (Coco 
et al., 1992; Deutch et al., 1991; Kalivas and Duffy, 1995; Morrow et al., 1997; Morrow 
et al., 2000; Sutoo and Akiyama, 2002). However, after chronic stressors the 
concentration and metabolism of DA decreases in the NAc (Imperato et al., 1993; 
Mangiavacchi et al., 2001). Glutamate afferents mediate the firing of DA neurons, 
particularly burst firing (Harnett et al., 2009; Overton and Clark, 1992; Seutin et al., 
1993). Therefore, changes in excitatory transmission may change the rate of DA neuron 
firing and subsequently the release of DA in target regions. In Chapter III, I have shown 
that activation of α1-ARs increases excitatory transmission in RLi DA neurons. Since NE 
centers are engaged during stress and there are noradrenergic projections to the RLi, I 
hypothesize that acute restraint stress increases glutamatergic transmission in much 
the same way as the application of NE and methoxamine. In order to test this 
hypothesis, electrophysiology experiments could be done in animals following restraint 
stress. The stressor mimics the actions of methoxamine, and after acute restraint 
stress, there may be an α1-AR dependent increase in frequency of sEPSCs on RLi DA 
neurons compared to control animals. This increase in sEPSCs could be blocked by a 
systemic injection of prazosin prior to administration of the stressor or reversed by 
applying prazosin to the slice. If there is no increase in sEPSC frequency following 
restraint stress, another stressor such as foot shock or exposure to predator odor could 
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be used, or it might indicate that this mechanism is not involved in the stress response. 
NE has also been shown to be involved in attention related behaviors and perhaps this 
might be the reason for the NE modulation of RLi DA neurons (Aston-Jones et al., 2000; 
Aston-Jones and Cohen, 2005; Bouret and Sara, 2004). Another explanation is that the 
effect occurs following stress but is transient and cannot be identified through 
electrophysiology recordings; Figure 11 does indicate that the α1-AR mediated increase 
in excitatory transmission may be transient. In recordings following chronic restraint 
stress, one might expect to see no change or decreases in glutamatergic transmission 
on RLi DA neurons since there are decreases in DA levels after chronic stressors.  
These experiments may indicate whether the α1-AR mediated increase in 
excitatory transmission onto RLi occurs as part of the stress response. If this action 
occurs following a stressor, further investigations into the mechanisms of the α1-AR 
mediated increase in excitatory transmission may give clues towards the development 
of treatments for pathological conditions that arise due to stress, such as anxiety 
disorders, depression, or PTSD. 
 
Activation of α1-ARs may underlie stress induced immediate early gene 
expression in RLi dopamine neurons 
An increase in c-fos expression following exposure to a stressor indicates that RLi DA 
neurons are recruited during stress (Deutch et al., 1991). Identification of the 
neurotransmitter system underlying the stress-induced c-fos expression allows for 
further insights into the actions of RLi DA neurons in the stress response. One 
hypothesis is that RLi DA neurons are recruited by NE through activation of α1-ARs 
during stress. In order to investigate this hypothesis, we attempted to block stress-
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induced increases in Zif268, an immediate early gene also known as Egr-1, in RLi DA 
neurons with a systemic injection of prazosin, an α1-AR antagonist, prior to 
administration of the stressor. Our initial attempts at this blockade were inconclusive 
(see Figure 17 in Appendix A). Therefore, it might be worthwhile to repeat these 
experiments by changing some of the experimental parameters. For example, although 
we used a dose of prazosin (2 mg/kg) within the range of those used in the literature 
perhaps a different dose of prazosin or a different α1-AR antagonist altogether, such as 
terazosin or HEAT (2-[[beta-(-4-hydroxyphenyl)ethyl]aminomethyl]-1-tetralone) might 
yield better results (Greenwell et al., 2009; Le et al., 2011). We have also made 
preliminary investigations into the timeline of stress induced Zif268 expression and find 
that prolonging the time from the start of the stressor before perfusion of the mouse may 
maximize Zif268 expression (see Figure 18 in Appendix A). This gives a larger window 
to see a reduction with the antagonist. After the preliminary time-course experiments, 
the Zif268 antibody stopped working and we could not get adequate staining above 
background with new lots of antibody. Recently, the lab has begun fluorescent c-fos 
immunohistochemistry. Therefore, future experiments in this area could use c-fos 
immunohistochemistry. One caveat with these future studies is that the systemic 
injection of the α1-AR antagonist won’t delineate whether activation of α1-ARs in the RLi 
or another brain region or even peripheral α1-ARs underlie the stress-induced Zif268 
expression in RLi DA neurons.  Therefore, the best approach is to inject the α1-AR 
antagonist directly into the RLi through a cannula prior to administration of the stressor. 
It is possible that a different neurotransmitter system is involved in the 
recruitment of RLi DA neurons during stress. A prime candidate might be CRF. CRF 
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concentration is known to increase during stress, and CRF has been shown to increase 
excitatory transmission onto dopamine neurons of the VTA and may also have actions 
within the RLi (Bonci and Borgland, 2009; Valentino et al., 1993). If prazosin fails to 
block stress induced increases in Zif268 expression, perhaps CRFR antagonists might 
be a good step to try next. Determining the neurotransmitter system underlying the 
recruitment of RLi DA neurons during stress opens the door for many future 
investigations into behaviorally relevant actions of RLi DA neurons.  It could possibly 
uncover a novel mechanism involved in the stress response that could lead to more 
effective treatments for anxiety disorders or PTSD. 
 
Summary 
 The heterogeneity of DA neurons has been a topic of active research in the last 
few years. It has become apparent that different molecular expression profiles, 
anatomical connectivity, and physiological properties likely lead to a functional 
heterogeneity among subsets of midbrain DA neurons. In this dissertation I report sub-
regions of DA neurons that project to the dorsal BNST of a TH-eGFP mouse. The 
largest numbers of dBNST projecting DA neurons were found in the VTA, RLi and 
caudal portion of the DR and adjacent vPAG. The results of these studies were used to 
guide electrophysiological studies of understudied RLi DA neurons. I found that RLi DA 
neurons lack Ih and have a higher membrane resistance than lateral VTA DA neurons 
(Williams et al., 2014). These are shared characteristics among other midline DA 
neurons such as those of the vPAG and PFC projecting medial VTA DA neurons and 
influence how a neuron responds to synaptic input (Lammel et al., 2011; Li et al., 
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2013a). Since there is a substantial NE input to the RLi DA neurons and they project to 
the BNST and PFC, regions heavily involved in stress and anxiety circuitry, I examined 
the effects of NE on excitatory transmission of RLi DA neurons (Mejias-Aponte et al., 
2009). I found that NE increased excitatory transmission onto RLi DA neurons via 
activation of α1-ARs. In addition, activation of α2-ARs leads to a mild decrease in 
excitatory transmission (Williams et al., 2014). NE may recruit RLi DA neurons during a 
variety of behaviors such as stress or disturbances in homeostasis (Deutch et al., 
1991). Due to their projections to the BNST and PFC, RLi DA neurons may also play a 
role in stress-induced reinstatement of drug-seeking or working memory, which is 
impaired in psychiatric disorders such as schizophrenia. In addition, the vPAG DA 
neurons play a role in the sleep-wake cycle and treatments of sleep related disorders 
may act on this system (Lu et al., 2006; Mitchell et al., 2008). In fact, prazosin, an α1-AR 
antagonist, is currently used to reduce severity of symptoms and treat sleep 
disturbances associated with PTSD (Mohsenin and Mohsenin, 2014; Raskind et al., 
2007; Taylor et al., 2008). If the RLi DA neurons are indeed involved in stress, anxiety, 
and addiction related behaviors, their further characterization may lead to effective 
novel treatment mechanisms for PTSD, anxiety disorders, and drug addiction. 
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APPENDIX A 
 
Stress induced Zif268 expression in dopamine neurons 
 As mentioned in Chapter IV, we confirmed that stress increases immediate early 
gene expression in RLi DA neurons of mice. After a 60 min session of restraint stress 
there is an increase in the percentage of Zif268 positive, TH positive cells in the RLi and 
lateral VTA of adult mice following restraint stress (Figure 15). This stress-induced 
Zif268 increase does not occur in dorsal raphe DA neurons, which is why RLi DA 
neurons were the focus of the electrophysiology studies. Since 3-4 week old mice were 
required to visualize viable cells in the RLi for electrophysiology studies, we confirmed 
that stress induced increases in Zif268 expression in RLi DA neurons also occur in 
adolescent mice (Figure 16). 
Since I found that the activation of α1-ARs increases excitatory transmission onto 
RLi DA neurons, we hypothesized that this increase in excitatory transmission was 
responsible for recruiting RLi DA neurons during stress. In order to test this hypothesis 
we attempted to block the stress induced Zif268 expression in RLi DA neurons through 
systemic injection of prazosin, the α1-AR antagonist, 30 minutes prior to the start of the 
stressor. This initial attempt was inconclusive (Figure 17).  In all of the above 
experiments, animals were perfused immediately upon cessation of restraint, 60 
minutes from the start of the stressor. We hypothesized that increasing the time from 
the start of the stressor to perfusion might give larger increases in protein expression. 
This would give a larger window to block Zif268 expression with prazosin. Indeed, 
waiting 45 minutes after the cessation of the stressor to perfuse the animal does give 
89	  
	  
larger increases in Zif268 expression (Figure 18). After the preliminary time-course 
experiments, the Zif268 antibody (Santa Cruz sc-110 lot L3107) stopped working and 
we could not get adequate staining above background with a new lot (Santa Cruz sc-
100 lot B2513) of antibody so we did not pursue this further. Potential future directions 
related to these data are outlined in Chapter IV. 
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Figure 15: Restraint stress increases Zif268 expression in TH+ neurons of 
the VTA and RLi, but not the DR in adult mice. 
(A) Image taken at 20x on a confocal microscope of a coronal section of the RLi 
showing TH (green) and Zif268 (red) immunohistochemistry. This mouse was 
perfused immediately after a 60 min session of restraint stress. Inset: close up of 
colocalized zif268 and TH positive cells. (B) Cell counts of the percent of TH cells 
that are zif268 positive in the VTA in naïve mice, mice perfused immediately after 
a 60 min restraint session, and mice perfused 60 min after the start of 6 min 
forced swim stress (F(2,20)=4.99, p=0.018), (C) RLi (F(2,20)=4.14, p=0.031), 
and (D) dorsal raphe (F(2,9)=0.066, p=0.94. A one way ANOVA was used 
followed by Tukey’s multiple comparisons test when p<0.05. * indicates p<0.05 
and the n for each group is listed on the graph. 
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Figure 16: Restraint stress increases Zif268 expression in TH+ neurons of 
the RLi, but not the VTA in adolescent mice. 
(A) Cell counts of the percent of TH cells that are zif268 positive in naïve mice 
and mice that undergo 60 min restraint stress session in the RLi (t(14)=2.72, 
p=0.017), and (B) VTA (t(13)=1.80, p=0.096). Below each graph is a brain atlas 
diagram from Paxinos and Watson and the black box indicates the region used 
for cell counting. A student’s t-test was used to determine statistical 
significance. *indicates p<0.05 and the n for each group is listed on the bar 
graph.	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Figure 17: Prazosin (2 mg/kg) does not block stress-induced Zif268 
expression in the RLi. 
Cell counts of the percent of TH cells that are zif268 positive in the RLi 
(F(2,26)=8.610, p=0.001). A one way ANOVA was used followed by Tukey’s 
multiple comparisons test. * indicates p<0.05, and ** indicates p<0.01. 
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Figure 18: Time course of stress-induced Zif268 expression in the RLi. 
Cell counts of the percent of TH cells that are zif268 positive in the RLi following 
a 60 minute restraint stress session (F(4,11)=11.8, p=0.0006). A one way 
ANOVA was used followed by Tukey’s multiple comparisons test. * indicates 
p<0.05, ** indicates p<0.01, and the n for each group is listed on the bar graph. 
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APPENDIX B 
 
Using optogenetics to investigate the actions of RLi dopamine release in the 
BNST 
 
 Since I faced technical difficulties with electrophysiology recordings in RLi DA 
neurons in animals over 4 weeks old, we decided to investigate the downstream actions 
of RLi DA in the BNST. This section contains some preliminary studies from an 
optogenetics pilot project. An AAV-DIO-ChR2-YFP virus (300nl) was injected into the 
RLi (AP = -3.98; ML = 0; DV = -3.98) of TH-cre mice. Expression of ChR2 was present 
in the RLi and fibers can be seen in the dBNST (Figure 19). There was strong ChR2 
expression in the RLi, and there was some spread of the virus into the interfascicular, 
medial PBP, and paranigral nuclei in some animals. The images in figure 19 were taken 
from slices that were fixed and immunostained following electrophysiology recordings 
so the antibody penetration is rather weak. These images indicate that there is ChR2 
expression in the RLi and dBNST, but the fidelity of the viral expression cannot be 
determined. It appears that there is expression of ChR2 in some TH+ neurons, but it is 
difficult to determine how much ectopic expression of ChR2 is present. If these 
optogenetics experiments were to continue, better images and accurate cell counts are 
needed to address the issue of fidelity (Lammel et al., 2015; Stuber et al., 2015). 
The next step is to elicit DA release from the terminals of RLi DA neurons in the 
dBNST. Different light stimulation protocols were attempted while recording sEPSCs 
from dBNST neurons. dBNST cells were recorded in areas of high YFP-ChR2 
expression as visualized by fluorescence on the electrophysiology rig. Prior studies in 
the lab indicate that DA increases sEPSC frequency in the BNST so it is possible that 
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the right light stimulation protocol could increase sEPSC frequency onto dBNST 
neurons (Kash et al., 2008). At first, we started with lower stimulation frequencies 
(varied from 2-10Hz, 5-15 pulses, 5ms/pulse) because we were worried about depleting 
DA quickly and there was the possibility of glutamate corelease from RLi DA neurons. 
Also, these stimulation frequencies cover the range of non-burst firing seen in VTA DA 
neurons (Paladini and Roeper, 2014). No light evoked EPSCs were witnessed in any of 
the stimulation protocols and we did not see much change in sEPSC frequency or 
amplitude (data not shown). We expected that we would see light evoked EPSCs since 
there is evidence of glutamate corelease in midline DA neurons (Hnasko et al., 2010; 
Stuber et al., 2010), therefore it is likely that the stimulation did not elicit DA release. 
Therefore, the stimulation frequencies were increased with varying results (10-20Hz, 5-
15 pulses, 5ms/pulse). In some cells, the same stimulation frequency was repeated a 
few times while in others the frequency of stimulation was increased every six minutes 
to see if one proved more successful than others. A few examples of these cells are 
shown in Figure 20. There are a few possible explanations for the variety of responses 
seen in Figure 20D. The BNST is composed of many different cell types so the different 
types of responses could be due to recordings from different types of BNST neurons 
(Hammack et al., 2007). In addition, the different stimulation protocols and the variability 
of ChR2 expression near any given cell may give different levels of DA release. We also 
can’t confirm that we are in fact getting DA release with any of the stimulation protocols. 
Therefore, if optogenetics experiments investigating the role of RLi DA input to the 
BNST were to continue, slice amperometry is necessary to determine the correct 
stimulation protocol to elicit DA release in the BNST.	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Figure 19: Optogenetic targeting of the RLi dopamine input to the BNST. 
(A) Confocal image at 20X showing colocalization of ChR2 (green) (300 µL 
injection of AAV-DIO-ChR2-eYFP) with TH (red) in the RLi of a TH-cre mouse. 
(B) Confocal image at 40X showing colocalization of ChR2 (green) with TH 
(red) in the BNST. 
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Figure 20: Optogenetic stimulation of the RLi dopamine input to the BNST. 
(A) Graph of the sEPSC frequency and amplitude of a BNST neuron from a TH-cre 
mouse that was injected with ChR2 in the RLi. This cell had a decrease in sEPSC 
frequency after stimulation with blue light. Each blue arrow represents a stimulation 
protocol corresponding to the legend to the right of the graph. Change in size of the 
arrow indicates an increase in the stimulation frequency or number of pulses. (B) 
Example of a cell with an increase in sEPSC frequency after stimulation with blue 
light. (C) Example of a cell with an increase in sEPSC amplitude following 
stimulation with blue light. (D) Pie chart indicating the varied responses in sEPSCs 
of BNST neurons after stimulation with blue light. 
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APPENDIX C 
 
Activation of α1-ARs increases sEPSC frequency onto vPAG dopamine neurons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21:  Methoxamine increases sEPSC frequency but not amplitude 
onto vPAG dopamine neurons.   
(A,B) A 20 min application of 100 µM methoxamine increases mEPSC 
frequency onto vPAG dopamine neurons (t(4)=2.87, p=0.046), but has no 
change on amplitude (data not shown). A paired student’s t-test was used to 
determine statistical significance,* denotes p < 0.05, n=5. 
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